rfhg_69331.1

Basic information about the TSS

---

TSS ID: rfhg_69331.1 Species: human Chr: chr5		Start: 79612705 End: 79612713 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3722230,EH38E2385615)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000503620.1:-87 GeneID: 167153 HGNC/MGI_ID: HGNC:26776 UniProt_ID: Nearer transcript ids and distances: ENST00000508620.5:-130 ENST00000514095.5:-130 ENST00000296783.7:-132 AK095818:-132 ENST00000502269.1:-185 ENST00000515807.5:-202 ENST00000428308.6:-220 BC026061:-220 ENST00000453514.6:-264 NM_001388124.1:-264 NM_001388108.1:-264 NM_001388094.1:-264 NM_001388120.1:-264 NM_001388121.1:-264 NM_001297744.3:-264 NM_001388133.1:-264 NM_001114393.3:-264 NM_001349548.2:-264 NM_001388119.1:-264 NM_001388110.1:-264 NM_001349550.2:-264 NM_001388111.1:-264 NM_001388112.1:-264 NM_001388096.1:-264 NM_001388134.1:-264 NM_001388128.1:-264 NM_001388097.1:-264 NM_173797.5:-264 NM_001388093.1:-264 NM_001388116.1:-264 NM_001388107.1:-264 NM_001388125.1:-264 NM_001388102.1:-264 NM_001388117.1:-264 NM_001388122.1:-264 NM_001388106.1:-264 NM_001388129.1:-264 NM_001388109.1:-264 NM_001388136.1:-264 NM_001388137.1:-264 NM_001388118.1:-264 NM_001388105.1:-264 NM_001388132.1:-264 NM_001388131.1:-264 NM_001388130.1:-264 NM_001388098.1:-264 NM_001388113.1:-264 NM_001388135.1:-264 NM_001388114.1:-264 NM_001349551.2:-264 NM_001297745.3:-264 NM_001114394.3:-264 NM_001349549.2:-264 NM_001388101.1:-264 NM_001388099.1:-264 NM_001388127.1:-264 NM_001349554.2:-264 NM_001349552.2:-264 NM_001388100.1:-264 NM_001388123.1:-264 NM_001349553.2:-264 NM_001388095.1:-264 NM_001388115.1:-264 NM_001388103.1:-264 NM_001388126.1:-264 BC047581:-264 ENST00000504233.5:-270 AL833136:-270 ENST00000423041.6:-272 view more...

Gene_name: terminal nucleotidyltransferase 2 Gene_symbol: TENT2 Gene_synonyms: FLJ38499 GLD2 TUT2 Gene_source: HGNC:26776

TATA-Box annotation

---

Distance to TSS:	268
Nearest PromoterID:	NM_001349549
Entrez ID:	167153
Nearest Unigene:	Hs.418198
Nearest Refseq:	NM_173797
Nearest Ensembl:	ENSG00000164329
Gene Name:	terminal nucleotidyltransferase 2
Gene Alias:	APD4|GLD2|PAPD4|TUT2
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TENT2 p2@TENT2 p3@TENT2 p4@TENT2 p5@TENT2 p6@TENT2 p7@TENT2 p8@TENT2
Sample		p1@TENT2	p2@TENT2	p3@TENT2	p4@TENT2	p5@TENT2	p6@TENT2	p7@TENT2	p8@TENT2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.53	30.58	2.53	3.31	0.97	0.58	0.78	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	15.98	25.90	1.62	2.63	0.40	2.43	1.01	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	14.27	27.59	3.28	2.31	0.96	1.35	1.74	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.44	25.37	3.74	1.46	1.04	1.04	1.46	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	14.40	22.27	2.70	4.50	0.45	1.57	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	15.50	21.90	3.29	2.71	0.19	0.39	1.36	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	19.61	33.99	5.66	3.70	0.65	1.31	2.40	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.29	30.52	3.15	3.63	0.97	1.94	1.70	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	16.67	30.56	3.42	1.92	0.85	1.71	1.50	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.61	65.50	9.85	3.48	2.32	2.90	4.06	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	28.30	60.64	9.70	5.26	0.81	2.83	2.43	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	26.43	69.11	9.76	4.07	0.81	3.66	3.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	23.21	3.71	1.93	0.81	0.64	0.48	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	22.85	3.01	1.65	0.60	0.30	0.60	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	19.10	3.95	0.66	1.10	0.00	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	18.36	1.51	1.26	0.00	0.00	0.50	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.29	2.62	0.66	0.22	1.09	0.87	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	20.25	0.84	0.84	0.42	0.42	1.27	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.46	2.67	3.73	0.00	2.13	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	18.35	2.56	0.75	0.45	0.45	0.45	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.18	2.81	0.13	0.40	0.94	0.27	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	21.23	3.63	0.69	0.86	0.35	0.52	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	19.65	1.55	1.03	0.78	0.26	0.52	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	19.17	2.67	0.49	0.73	0.24	0.24	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.41	2.06	0.77	0.26	0.00	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	14.56	2.22	0.95	0.00	0.00	0.63	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.93	2.20	1.10	1.10	0.55	0.00	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	18.86	3.30	1.41	0.94	0.47	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	16.48	3.23	1.13	0.81	0.16	0.32	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	19.73	3.26	1.63	0.90	0.54	0.00	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	17.17	1.05	0.42	0.00	0.42	0.21	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	18.37	1.76	1.37	0.59	0.00	0.39	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	19.84	3.17	0.63	0.63	0.63	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	25.40	3.63	1.32	0.82	0.00	0.16	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	16.27	2.43	1.12	0.93	0.00	0.75	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.35	0.77	1.72	0.57	0.19	0.19	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	20.23	2.45	0.82	0.41	0.41	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	17.53	2.01	0.20	0.81	0.20	0.40	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	18.91	1.62	1.89	0.27	0.81	0.81	0.54	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.32	2.64	1.44	0.72	0.48	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	16.94	1.88	1.18	0.71	0.94	1.18	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	18.59	3.22	1.17	0.73	0.44	0.15	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	17.93	2.74	1.69	0.84	0.21	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	17.83	3.32	0.70	0.17	0.17	0.52	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	18.87	3.41	1.61	0.40	0.00	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.75	1.40	0.70	0.47	0.70	0.23	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	19.91	2.16	2.16	0.96	0.24	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.20	1.79	0.30	0.60	0.30	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.67	1.68	0.48	0.72	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	15.57	1.01	0.61	0.40	0.40	0.00	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	22.54	2.66	1.64	1.23	0.41	0.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.02	3.78	1.11	0.44	0.44	0.67	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	13.99	13.99	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.87	3.55	1.77	0.00	0.00	0.35	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.56	1.66	1.33	0.00	0.66	0.66	0.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	22.65	6.71	1.68	0.84	0.84	4.19	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	25.26	3.21	3.21	1.84	1.38	1.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	21.39	4.54	1.30	0.32	0.32	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	23.12	3.85	2.57	0.32	0.32	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	28.92	2.83	2.83	1.57	0.00	3.14	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.86	2.12	2.12	0.00	0.00	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	19.07	2.80	3.36	0.56	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	13.53	4.78	1.59	1.59	0.00	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.10	3.06	0.00	0.68	0.34	1.70	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	24.04	2.92	1.62	0.65	0.65	2.27	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	24.14	2.13	0.71	0.35	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	71.08	7.90	0.00	0.00	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	21.45	2.44	1.46	0.00	0.00	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	21.82	1.49	0.99	0.00	0.50	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	18.30	0.94	0.94	0.00	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	23.85	1.66	1.32	0.33	0.00	1.32	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	34.65	1.55	1.24	0.62	0.00	0.62	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.05	1.53	0.92	0.61	0.92	1.22	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	25.97	0.79	0.48	0.00	0.63	0.00	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	21.82	0.64	1.76	0.16	0.80	0.32	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	23.54	1.15	0.76	0.00	0.64	0.25	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	23.17	0.75	0.75	0.75	0.00	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	17.75	0.67	1.00	0.33	0.00	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	14.67	0.64	0.64	0.64	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	2.20	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.03	0.00	0.45	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	15.12	0.17	1.22	0.17	0.17	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	32.86	2.15	2.54	0.59	0.00	0.20	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	21.62	2.06	2.57	1.03	0.26	0.26	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	23.42	2.51	1.95	0.56	0.84	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	21.16	1.76	1.76	0.00	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	34.59	3.06	2.73	0.56	0.80	0.48	0.32	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	27.43	1.61	3.23	0.32	0.32	1.29	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	26.13	1.60	0.53	0.00	0.00	0.53	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	22.26	0.56	0.56	0.00	1.67	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	25.79	1.25	0.83	0.83	0.42	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	26.62	1.76	2.01	0.75	0.50	0.50	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	23.56	2.62	1.31	0.98	0.33	0.98	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	15.53	0.91	0.61	0.61	0.61	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	6.85	0.66	0.00	0.22	0.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	5.38	1.08	0.00	0.36	0.00	0.72	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	10.25	1.62	0.72	0.36	0.18	0.18	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	1.67	0.00	0.00	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	7.81	0.62	0.21	0.00	0.21	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	21.86	2.40	0.69	0.69	0.34	0.11	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	19.84	2.45	1.22	0.00	0.24	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	18.87	4.04	0.45	0.45	0.00	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	16.06	1.74	2.17	1.30	0.43	0.00	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	0.00	0.00	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	23.32	2.69	1.79	1.79	0.90	0.90	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	18.97	3.79	5.06	0.00	0.00	2.53	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.96	2.64	0.66	0.00	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	18.19	2.27	1.30	0.97	0.32	0.32	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	17.96	0.00	1.94	0.97	0.97	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	0.59	0.59	0.59	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.57	1.51	2.64	0.75	0.38	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	23.22	2.90	2.90	0.73	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	1.25	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	16.31	1.15	0.82	0.16	0.49	0.33	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	2.73	0.00	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	13.12	1.36	1.21	0.45	0.15	0.30	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	21.43	5.89	2.14	2.14	0.00	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.04	2.27	0.76	0.57	0.38	0.38	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	12.30	2.67	1.34	0.80	0.53	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	2.93	2.93	0.98	0.98	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	14.43	1.99	1.00	0.33	0.33	0.66	0.17	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	2.40	1.20	0.00	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	10.62	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	16.12	2.74	2.57	1.03	0.34	0.34	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.45	1.46	1.94	1.46	0.49	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	17.83	1.90	2.28	0.76	0.38	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	3.63	0.00	1.21	1.21	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	23.94	2.28	1.14	0.57	0.00	1.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	15.82	1.28	2.14	0.64	0.43	0.64	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.00	0.77	1.29	1.03	0.77	0.52	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	19.24	3.28	0.47	0.00	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	13.51	0.64	2.57	0.32	0.96	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.27	1.43	0.00	0.71	0.00	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	13.45	2.34	1.75	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.37	3.01	1.20	0.00	0.90	0.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	9.50	0.00	3.56	1.19	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	22.89	0.51	1.53	2.03	0.51	1.53	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	17.57	2.55	1.02	1.02	0.25	0.76	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.17	0.64	1.91	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.12	2.59	1.29	0.86	0.43	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	14.61	1.06	1.48	1.27	0.21	0.85	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.70	2.03	1.45	1.45	0.00	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	0.94	0.00	0.00	0.00	1.89	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.05	1.86	1.02	0.00	0.17	0.17	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	0.00	0.00	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	0.00	2.11	0.00	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.72	1.07	1.50	0.64	0.64	0.43	0.43	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	1.20	2.41	0.60	0.60	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	17.50	1.46	0.73	1.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	15.40	1.84	2.30	0.46	0.23	0.69	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.66	3.05	1.27	0.76	0.51	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	18.79	3.10	2.89	0.62	0.83	0.62	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.32	2.75	0.31	0.61	0.61	1.53	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.99	3.82	2.87	1.43	1.43	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.97	5.10	2.66	0.89	0.67	0.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	3.05	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	21.05	1.11	0.00	0.55	0.00	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.95	3.18	1.85	1.06	0.53	0.53	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.09	2.18	1.45	0.73	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	12.04	2.82	0.74	0.37	0.25	0.00	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	9.41	2.05	0.51	1.37	0.00	0.00	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.24	0.63	0.84	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	29.28	6.62	0.70	1.05	0.35	0.00	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	20.55	6.31	2.59	1.13	0.65	0.49	0.16	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	25.36	4.03	1.34	0.45	0.89	1.04	0.45	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	67.89	16.74	7.57	3.33	3.21	2.52	1.15	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	59.13	17.29	5.89	2.63	1.63	1.13	0.75	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	56.90	15.70	6.37	3.41	3.07	0.80	0.46	0.23
Basophils, donor1	12241-129G9	38.97	11.77	4.71	2.62	2.35	0.52	0.26	0.00
Basophils, donor2	12242-129H1	74.32	22.73	7.58	6.49	5.41	1.08	1.80	0.00
Basophils, donor3	12243-129H2	60.71	15.58	4.41	2.35	1.62	0.15	0.59	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	10.13	0.43	0.22	0.00	0.00	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.11	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.69	1.26	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.69	0.42	0.21	0.21	0.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	15.66	0.69	0.69	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	26.27	0.90	0.54	0.36	0.36	1.26	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	18.96	27.82	2.47	5.77	1.96	0.00	2.68	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	26.32	23.99	2.79	5.82	1.16	0.70	2.10	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.02	24.62	4.16	3.52	2.88	1.28	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	103.42	0.00	31.03	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	56.36	12.96	6.76	1.69	0.00	0.00	1.13	0.56
CD14+ Monocytes, donor2	11305-117B9	67.19	13.92	14.11	2.97	3.90	0.93	0.56	0.56
CD14+ Monocytes, donor3	11381-118B4	55.54	14.27	10.76	1.98	3.29	1.32	1.54	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	89.72	19.53	11.32	2.26	4.25	0.57	0.28	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	97.42	12.89	15.16	1.52	6.07	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	114.73	22.68	15.12	1.97	7.23	0.33	0.33	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	66.20	6.50	17.49	1.59	3.47	2.02	0.29	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	57.93	6.94	9.66	0.91	2.11	0.30	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	63.96	9.95	13.03	1.90	3.55	1.18	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	57.42	7.03	14.90	1.51	3.18	1.17	0.33	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	50.23	7.45	11.59	1.10	1.93	1.10	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	73.14	11.40	11.65	0.74	2.48	0.74	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	70.68	13.90	14.69	1.96	3.13	0.78	0.59	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	71.93	16.20	17.45	2.31	3.38	2.49	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	68.55	19.15	12.84	2.18	3.92	3.05	1.74	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	55.49	9.37	11.47	2.34	1.40	0.47	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	70.76	20.59	13.20	2.64	1.06	0.53	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	66.56	18.86	14.42	2.22	7.77	2.22	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	58.31	7.14	15.62	1.04	2.68	0.89	0.00	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	50.69	5.79	12.37	1.60	2.39	1.00	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	53.51	7.91	11.45	1.04	3.33	0.83	0.42	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	49.65	6.18	12.13	0.69	1.60	2.29	0.23	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	55.19	9.05	8.14	0.00	5.20	0.23	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	52.38	14.40	9.17	0.87	3.06	0.87	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	78.55	17.75	18.83	1.61	4.03	2.69	0.81	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	75.02	19.71	20.24	2.09	6.11	1.22	2.09	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	87.11	25.25	18.10	2.10	5.47	1.26	1.68	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	58.60	10.29	11.39	1.29	2.02	1.10	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	59.53	12.33	15.85	2.11	2.11	1.76	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	68.88	10.97	12.72	3.07	3.07	1.32	1.32	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	74.11	12.90	17.96	1.57	2.79	2.79	0.52	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	66.16	16.35	18.96	1.49	2.60	1.86	0.00	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	96.35	23.71	18.75	3.45	4.96	3.23	1.72	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	40.95	7.37	13.10	0.82	3.28	0.82	0.41	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	54.01	15.07	13.68	2.78	3.25	0.46	1.16	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	61.71	17.17	10.67	1.39	3.48	1.86	1.16	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	48.17	10.03	7.63	3.71	4.14	0.44	0.44	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	65.37	13.63	8.32	1.39	2.77	2.08	0.92	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	42.89	9.96	7.15	1.30	3.25	0.65	0.87	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	88.45	8.41	11.83	0.78	4.20	0.62	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	73.35	8.03	10.83	0.87	3.14	0.87	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	90.75	11.59	11.15	1.34	4.91	0.22	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	68.90	10.46	9.19	1.02	1.53	1.28	1.02	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	80.58	12.73	13.39	2.63	1.76	2.42	0.00	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	70.74	10.74	4.42	1.05	1.68	1.05	1.05	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	46.74	32.52	10.16	4.06	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	58.31	28.48	12.88	4.07	4.07	2.03	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	53.85	31.07	10.36	3.11	6.21	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	60.23	37.31	6.93	7.46	8.00	2.67	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	82.02	26.27	12.87	5.36	5.36	2.14	2.14	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	46.33	23.16	8.42	2.81	4.91	1.40	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	54.90	26.67	11.77	1.57	2.35	0.78	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	64.60	21.09	10.55	7.91	2.64	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	101.92	77.26	18.08	6.58	7.40	3.29	3.29	1.64
CD19+ B Cells, donor2	11624-122B4	87.78	60.94	12.33	14.51	5.08	1.45	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	89.86	71.69	14.64	10.10	7.07	3.53	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	112.33	4.04	0.81	0.81	0.00	0.81	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	82.69	0.40	0.40	1.20	0.00	0.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	17.07	39.16	4.02	8.03	2.01	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	45.51	55.62	7.30	11.24	1.69	2.81	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	31.56	20.67	2.63	1.88	3.38	1.13	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	28.41	23.45	4.06	3.38	3.61	0.68	1.13	0.00
CD4+ T Cells, donor1	11225-116C1	151.75	43.56	5.36	8.93	6.43	0.71	1.43	0.00
CD4+ T Cells, donor2	11306-117C1	108.39	30.62	12.86	6.12	3.67	4.29	1.84	1.22
CD4+ T Cells, donor3	11382-118B5	95.16	29.28	10.67	3.66	2.44	1.22	1.22	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	66.11	14.80	9.95	2.55	4.34	0.77	0.51	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	67.38	9.88	7.86	1.35	3.82	0.90	0.90	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	75.89	11.79	12.07	2.59	3.74	0.00	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	119.00	18.02	8.06	2.37	3.79	1.42	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	125.72	16.86	9.13	2.11	4.21	3.51	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	131.85	23.07	6.59	0.00	6.59	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	43.79	9.54	9.54	1.59	2.60	0.72	0.87	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	46.60	7.29	8.47	1.19	2.54	1.53	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	42.88	7.09	5.48	1.45	1.77	0.97	0.32	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	91.45	21.07	8.52	1.79	2.69	1.34	1.79	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	85.60	21.31	12.23	2.80	5.59	3.14	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	94.16	19.80	11.88	2.64	3.52	1.32	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	73.79	13.07	8.01	2.11	7.59	1.26	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	59.63	2.49	3.32	0.21	1.45	1.04	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	54.46	5.68	5.68	0.33	1.67	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	127.27	20.40	8.97	4.08	3.26	0.54	0.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	159.18	30.55	15.01	5.36	3.22	1.61	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	98.63	16.14	10.76	0.00	3.59	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	68.98	10.94	8.90	1.67	4.64	1.11	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	48.31	7.36	7.80	1.95	0.87	0.43	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	60.10	11.14	6.51	1.05	3.99	0.84	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	84.94	24.77	6.57	3.54	2.53	1.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	77.55	19.06	8.23	3.03	4.77	2.60	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	103.72	17.00	9.59	4.36	5.67	1.31	0.87	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	104.91	17.32	11.88	1.48	5.94	0.00	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	79.39	15.69	5.54	3.69	2.77	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	92.12	8.37	6.98	2.79	2.79	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	120.74	24.37	12.18	4.43	2.77	0.55	0.83	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	143.80	22.09	13.25	2.21	3.68	1.72	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	83.16	12.32	10.78	3.08	4.62	0.00	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	105.64	10.74	8.95	1.43	4.66	3.22	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	88.64	11.08	8.31	0.00	4.15	2.77	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	125.72	45.84	5.89	10.15	3.93	0.98	2.29	0.65
CD8+ T Cells, donor2	11307-117C2	100.99	30.03	5.63	5.26	2.63	1.50	1.13	0.75
CD8+ T Cells, donor3	11383-118B6	95.95	40.15	10.10	9.09	2.78	2.02	2.02	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	21.33	5.51	2.29	2.06	1.15	0.92	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	19.41	4.07	1.44	0.96	1.44	0.24	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	19.97	4.10	3.01	1.64	1.37	0.00	0.82	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	30.92	11.71	3.00	2.40	0.60	1.80	0.60	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	23.04	5.28	4.32	2.16	0.72	0.48	1.20	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.01	11.37	2.96	1.14	0.00	0.68	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	16.51	7.82	1.52	0.65	0.65	1.09	0.22	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	13.42	6.32	2.90	1.32	0.53	0.53	1.32	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	20.40	8.91	2.35	3.05	0.47	0.47	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	22.04	11.77	3.02	2.11	2.11	0.60	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.11	9.88	2.61	2.03	0.00	1.45	1.16	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.79	11.72	2.93	1.60	0.27	2.40	1.07	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	22.76	24.51	2.19	2.63	1.31	0.00	1.31	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	19.58	16.85	5.47	3.64	2.28	0.00	2.73	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	32.07	19.39	2.98	5.97	2.24	0.00	0.75	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	19.09	8.64	2.52	0.36	1.44	0.72	1.08	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	29.92	8.34	2.01	0.86	1.44	0.58	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	18.15	4.71	3.54	1.41	2.59	0.94	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	21.55	12.68	2.22	0.63	0.63	2.22	1.90	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	20.61	11.38	1.85	0.92	1.23	0.31	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	18.27	9.94	4.49	1.60	0.32	0.32	2.56	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	18.74	13.39	6.50	1.15	0.38	0.76	1.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	14.98	8.28	3.15	1.58	0.39	1.58	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.15	6.81	3.78	3.03	2.27	2.27	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	69.05	30.51	5.62	4.82	1.61	3.21	1.61	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	69.94	24.48	4.90	2.80	1.40	0.70	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	84.15	24.04	9.02	4.01	1.00	4.01	3.01	4.01
Cardiac Myocyte, donor1	11525-119I4	56.66	1.83	0.00	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.34	2.96	0.99	0.49	0.49	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	16.00	3.16	0.53	0.53	0.32	0.00	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	33.28	0.69	0.00	0.00	0.00	0.35	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	16.35	1.42	0.36	1.07	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	25.49	1.25	1.14	0.11	0.11	0.34	0.00	0.11
Chondrocyte - re diff, donor2	11339-117F7	18.80	3.58	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	23.05	2.02	1.21	0.40	0.81	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	32.59	5.62	1.49	1.61	0.80	0.23	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	20.74	4.49	1.92	0.86	0.43	0.64	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	18.94	7.35	1.33	1.59	0.53	0.44	0.53	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	60.71	5.59	3.30	0.92	1.56	0.46	0.92	0.09
Corneal Epithelial Cells, donor1	11526-119I5	5.27	0.44	0.44	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	12.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.71	0.26	1.28	0.00	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	54.32	40.94	10.90	5.12	6.93	0.50	2.64	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	43.53	42.58	5.68	3.47	5.05	0.95	3.15	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	24.15	10.35	3.45	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	38.44	27.97	8.75	2.59	6.05	1.73	1.94	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	43.73	67.99	6.49	8.54	7.86	0.34	2.05	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	40.48	58.76	11.10	7.83	9.14	0.65	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	43.56	100.66	15.49	12.58	6.78	1.45	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	9.67	1.67	0.33	0.50	0.17	0.33	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	8.80	0.59	0.59	1.17	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	7.92	1.98	0.57	0.85	0.28	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	4.33	2.75	0.00	1.18	0.39	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.24	1.16	0.29	0.29	0.29	0.00	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	16.00	3.29	2.82	0.71	0.71	0.94	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	9.64	0.88	0.70	0.18	0.35	0.35	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	14.19	3.99	0.89	1.33	0.66	0.00	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	18.86	10.65	0.91	0.30	1.22	0.00	1.22	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	22.55	8.74	1.41	2.26	1.41	0.00	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	10.40	1.78	0.89	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	11.98	2.08	0.00	0.52	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	4.96	1.28	1.28	0.43	0.43	0.14	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	17.61	6.80	0.80	2.40	0.80	0.40	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	5.24	3.67	1.05	1.05	0.00	1.05	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	21.62	10.44	3.35	2.48	2.11	0.37	1.62	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	9.99	7.60	1.96	1.09	1.74	0.65	0.87	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	12.46	7.57	1.22	1.59	0.37	0.37	0.61	0.00
Endothelial Cells - Vein, donor1	11267-116G7	5.69	3.41	1.14	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	7.68	3.49	0.00	0.70	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	7.85	2.98	1.57	0.47	0.16	0.16	0.31	0.00
Eosinophils, donor1	12244-129H3	76.23	30.49	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	89.11	39.61	13.20	4.95	8.25	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	78.47	35.67	17.83	7.13	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.40	0.49	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	31.20	1.23	0.82	0.00	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.62	0.55	1.09	0.22	0.44	0.44	0.00	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.22	1.63	1.19	0.33	0.33	0.43	0.00	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	19.28	1.21	0.85	0.97	0.49	0.49	0.24	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	43.53	2.59	1.23	0.27	0.55	0.00	0.82	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.66	1.27	1.05	0.00	0.32	0.21	0.11	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	55.33	4.74	3.69	1.32	1.58	0.53	0.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	22.26	1.66	1.33	1.33	0.33	1.00	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	9.98	2.72	0.45	0.45	0.91	0.91	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	10.61	2.27	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	6.62	0.63	0.79	0.47	0.47	0.16	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	34.86	5.46	1.52	1.21	0.61	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	23.86	3.81	1.90	0.38	0.51	0.89	0.38	0.25
Fibroblast - Cardiac, donor6	11460-119B2	22.74	3.49	1.82	0.91	1.36	0.61	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	15.27	2.14	0.94	0.94	0.27	0.00	0.40	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.96	2.59	0.86	0.43	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	4.39	2.93	0.00	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	9.69	1.15	0.00	0.23	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	40.37	4.07	1.70	0.51	1.36	0.34	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	17.37	1.17	1.88	0.00	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	8.96	1.89	0.94	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	17.89	1.57	1.21	0.12	0.36	0.60	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	27.24	2.03	1.24	0.57	0.45	0.34	0.00	0.23
Fibroblast - Dermal, donor5	11454-119A5	33.32	1.22	2.44	0.52	0.52	0.52	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	35.41	1.14	2.27	0.81	0.32	0.16	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	33.52	1.04	2.08	0.00	1.04	0.00	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	36.42	1.31	1.57	1.31	0.79	0.52	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	28.73	1.19	1.19	0.40	0.40	0.66	0.40	0.26
Fibroblast - Gingival, donor3	11394-118C8	38.58	0.77	1.64	0.58	0.39	0.19	0.29	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	30.13	2.08	1.04	1.04	0.00	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.44	1.23	1.59	0.00	0.53	0.53	0.53	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	30.71	3.12	1.87	0.62	1.25	0.31	0.16	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	27.72	1.49	2.84	0.27	0.14	0.14	0.27	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	18.00	2.12	0.00	1.06	1.41	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	25.30	2.05	3.66	0.29	1.02	0.15	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	32.72	1.64	2.73	0.14	1.23	0.41	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	27.53	2.19	1.65	0.55	0.55	0.55	0.11	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	34.78	2.49	3.37	0.44	1.03	0.29	0.00	0.15
Fibroblast - Lung, donor1	11270-116H1	10.87	0.00	2.72	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	25.37	0.00	7.46	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	14.35	2.11	1.27	1.06	0.21	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	12.50	0.83	1.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	17.46	0.41	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	31.62	1.55	0.97	0.19	0.39	0.19	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	43.99	1.82	2.12	0.46	1.37	0.46	0.15	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	51.41	2.14	2.45	0.61	0.00	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.86	2.29	1.91	0.00	0.38	1.14	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	20.52	1.62	2.16	0.27	0.54	1.35	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	18.67	1.39	1.62	0.70	0.58	0.12	0.12	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	11.72	2.32	0.66	0.44	0.22	0.11	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	15.04	1.42	0.61	0.00	0.20	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.61	1.58	0.79	0.00	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	85.53	2.78	2.18	0.60	0.99	0.60	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	29.13	1.24	0.53	0.18	0.00	0.00	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	29.76	1.38	1.18	0.39	0.39	0.59	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	46.33	5.11	1.81	1.20	0.60	0.60	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	44.58	2.48	1.84	0.65	0.86	0.11	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	73.64	4.05	2.02	0.51	0.51	0.76	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	30.03	0.66	0.82	0.16	0.49	0.16	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	74.39	5.61	3.21	2.01	1.20	0.00	0.80	0.20
Fibroblast - skin normal, donor2	11561-120D4	41.89	4.52	1.61	1.51	0.50	0.70	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	84.32	5.14	3.63	0.91	1.21	1.51	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	39.68	1.49	1.41	0.50	0.25	0.25	0.17	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	55.05	3.59	2.74	0.68	1.03	0.51	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	58.79	3.28	1.97	0.66	0.33	0.33	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	37.39	2.02	1.38	0.32	0.64	0.32	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	19.40	0.84	1.01	0.51	0.00	0.17	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	23.52	1.10	2.04	0.16	0.31	1.25	0.00	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	56.65	1.74	4.36	1.74	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	18.38	2.08	0.52	0.35	0.35	0.00	0.52	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	21.60	4.16	1.04	0.52	1.04	0.00	0.78	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.44	2.04	1.53	0.00	0.77	0.51	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	6.12	9.95	0.00	0.00	0.00	2.30	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	7.02	6.38	0.64	0.64	1.28	0.64	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	22.25	8.84	1.71	3.14	0.57	0.86	1.43	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	33.09	17.92	1.65	4.69	1.38	0.83	1.38	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	27.40	7.31	1.37	2.28	0.91	0.46	1.37	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	18.82	9.51	0.79	0.99	0.79	0.59	1.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	34.10	14.80	0.79	3.97	0.26	1.06	1.06	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.40	9.78	0.65	3.26	0.98	0.00	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	12.38	11.94	1.33	3.54	0.00	0.88	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	19.93	16.68	0.85	2.26	1.13	0.57	1.13	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	25.98	14.28	1.60	2.96	1.23	1.11	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	11.01	12.89	0.81	2.42	0.81	1.61	1.61	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	19.58	11.52	0.50	2.48	0.62	0.50	0.74	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	23.39	13.15	2.49	2.35	0.69	1.25	0.97	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.42	13.01	1.02	2.44	0.41	0.61	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	16.66	10.50	1.14	1.83	1.37	0.00	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	20.06	14.57	1.12	1.74	0.50	0.87	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	20.33	14.43	0.87	1.75	0.66	1.09	1.09	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.93	9.16	2.36	1.48	1.18	0.00	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.48	10.33	2.07	1.75	0.64	0.95	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	20.11	10.72	1.12	2.23	0.89	0.45	1.12	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	22.58	7.26	2.22	1.01	0.00	0.81	1.41	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	20.70	8.31	1.36	1.36	0.68	0.51	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	22.08	16.05	1.51	3.10	1.95	0.18	2.22	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	34.86	13.01	2.08	1.77	1.77	0.10	0.73	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.54	14.00	1.20	2.22	1.54	0.17	0.85	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	26.45	10.40	2.10	1.00	1.22	0.44	0.44	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.96	10.65	1.83	3.08	1.25	0.25	0.83	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.83	13.48	0.82	1.84	1.43	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.46	6.81	1.44	1.44	0.62	0.41	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	24.56	9.34	1.50	2.31	0.46	0.23	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	23.85	9.51	2.00	2.33	0.67	0.17	0.50	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.48	5.95	0.88	1.32	0.88	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	31.98	7.26	2.58	0.98	1.35	1.11	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.75	11.18	1.30	0.97	0.49	0.16	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	31.11	5.13	2.57	1.60	1.60	0.64	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	21.70	5.97	1.04	1.04	0.47	0.28	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.40	6.17	1.42	1.58	0.32	0.79	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	22.20	4.56	1.22	1.22	0.00	1.52	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	23.31	7.94	2.09	1.46	0.94	0.42	0.42	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.93	4.61	1.54	0.66	0.66	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	20.48	6.73	1.12	1.12	0.84	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	16.85	6.48	2.13	2.13	1.20	0.19	0.37	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	12.30	7.75	1.60	0.80	0.80	1.07	1.87	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.46	9.03	2.30	1.99	0.31	0.00	1.07	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	17.36	7.51	0.91	1.68	0.78	0.13	0.39	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.50	6.51	1.63	1.36	0.81	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	20.46	5.16	3.69	1.47	0.55	0.00	0.92	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.27	3.95	3.29	0.88	1.10	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	48.60	4.96	1.98	0.99	1.98	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	20.84	3.56	1.58	0.92	0.26	0.40	0.40	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.77	2.42	1.61	1.61	0.61	0.20	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	65.83	11.44	6.61	0.51	4.07	0.00	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	24.88	30.46	1.99	4.78	1.00	0.60	1.99	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	24.34	16.02	1.69	2.16	0.62	0.92	0.92	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	27.82	25.78	2.45	4.09	1.02	1.02	1.43	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	7.51	9.07	0.00	2.50	0.31	0.94	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	7.35	6.78	0.00	1.41	1.13	0.00	1.41	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.53	21.22	0.92	1.84	1.38	2.77	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	17.32	0.00	4.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	11.60	14.31	1.16	3.09	1.55	1.16	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	22.46	1.60	3.21	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	12.17	17.39	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	7.81	16.92	1.95	2.93	0.00	0.65	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	12.77	13.18	1.65	4.53	0.00	2.47	2.06	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	13.33	3.33	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	14.54	15.38	0.56	3.36	1.12	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	16.02	13.40	1.96	3.27	0.98	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.10	14.26	0.84	3.36	0.84	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	19.08	14.63	0.95	1.91	1.91	0.64	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	13.59	12.23	0.68	1.36	0.68	0.68	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	16.71	0.00	6.26	0.00	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	15.46	10.88	1.72	2.86	0.57	1.15	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.39	7.70	0.89	2.07	0.59	0.59	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	6.78	0.00	5.08	1.69	3.39	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	18.23	15.33	1.24	3.73	0.00	1.24	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	13.35	16.11	1.61	2.99	1.38	0.92	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	10.54	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	16.91	9.99	2.31	0.38	1.15	0.77	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	14.67	11.08	2.28	3.59	0.65	1.96	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.05	14.71	0.00	1.34	0.00	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	25.04	12.71	3.47	3.08	0.39	0.39	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	28.07	24.31	2.40	4.45	1.71	0.68	2.74	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	17.39	0.00	0.00	2.48	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	24.06	9.44	0.00	0.94	0.00	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	20.52	9.05	0.60	1.81	0.60	0.00	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	26.96	11.70	1.53	1.53	0.51	1.02	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	29.51	16.75	1.20	1.99	0.80	0.00	1.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	30.59	15.79	2.96	1.97	0.49	0.49	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	38.95	16.53	3.54	1.18	0.00	4.72	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	22.17	11.09	1.17	1.17	1.17	1.75	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	37.74	13.61	2.19	0.44	0.00	1.32	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	24.58	12.72	1.70	0.85	0.85	0.85	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	20.89	11.94	0.60	1.19	0.00	2.39	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.44	13.59	0.97	1.46	0.97	0.49	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	1.14	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.46	0.83	0.42	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	1.12	1.12	0.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	25.37	1.90	2.85	0.63	0.63	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.87	1.67	0.00	0.00	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.97	0.81	1.28	0.35	0.35	0.58	0.23	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	14.85	0.68	0.68	0.34	0.17	0.34	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	11.83	0.91	0.46	0.68	0.23	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.32	0.98	1.75	0.11	0.22	0.33	0.22	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	11.82	1.50	0.86	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	13.56	2.15	0.86	0.22	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	13.45	1.87	0.87	0.50	0.25	0.62	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.01	1.54	1.03	0.51	0.17	0.17	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.61	0.64	0.96	0.00	0.00	0.32	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	3.36	2.24	0.56	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2.60	0.43	0.43	0.43	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	2.64	2.64	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.05	0.71	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	2.91	0.00	0.73	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	13.11	2.80	1.40	1.40	0.17	0.35	0.00	0.00
Hepatocyte, donor1	11523-119I2	53.27	1.21	3.63	0.00	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	52.79	0.00	4.31	1.08	0.00	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	53.99	0.61	1.23	0.61	1.84	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	31.98	22.84	5.22	1.96	1.96	5.22	1.96	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	44.04	6.29	2.10	0.70	0.52	0.35	0.70	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	15.37	3.84	0.27	0.69	0.41	0.00	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	15.92	3.18	3.18	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	41.53	9.69	2.77	4.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	10.01	5.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	12.81	5.13	5.13	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	32.49	12.99	4.87	3.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	30.01	16.67	1.67	1.67	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	7.26	7.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	41.03	13.23	3.97	2.65	1.32	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	29.93	15.52	5.54	1.11	2.22	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	5.24	0.00	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	31.49	18.27	3.15	3.15	0.63	1.26	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	26.29	10.83	3.09	1.55	0.00	3.09	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	47.16	13.57	3.88	2.58	0.65	1.29	0.65	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	40.25	22.54	6.44	4.83	0.00	0.00	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	23.90	0.00	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	57.86	17.93	4.89	0.81	4.07	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	27.71	13.85	1.68	3.78	0.00	0.42	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	40.99	15.27	4.02	4.82	0.80	1.61	3.21	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	24.01	12.93	1.85	3.69	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	25.02	8.50	3.30	2.36	0.94	0.00	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	23.58	11.79	0.00	4.53	0.00	2.72	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	46.27	13.99	8.61	1.08	0.00	2.15	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	26.68	15.25	7.62	1.27	1.27	0.00	2.54	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	35.71	13.39	4.46	1.91	1.91	0.64	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	7.29	5.47	0.00	0.00	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	31.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	36.42	9.28	2.86	3.57	2.14	2.14	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	9.95	0.00	6.64	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	20.85	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	23.77	9.57	1.85	2.78	0.93	0.31	1.23	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	36.88	3.51	3.51	0.00	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	18.86	0.00	0.00	3.14	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	31.29	14.60	4.87	2.78	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	39.84	6.64	0.00	4.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	12.97	3.24	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	29.65	8.72	2.62	1.74	1.74	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	40.50	18.00	4.50	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	3.48	6.97	0.00	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	30.94	7.47	3.20	0.00	2.13	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	19.40	15.24	0.00	1.39	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	5.70	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	9.20	1.84	0.00	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	36.30	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	27.49	3.17	3.17	0.00	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	17.46	2.04	1.06	0.16	0.24	0.08	0.24	0.08
Keratinocyte - epidermal, donor2	11349-117G8	2.93	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	20.64	2.27	1.99	0.38	0.38	0.19	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	47.56	2.50	1.02	0.57	0.34	0.00	0.11	0.34
Keratocytes, donor1	11527-119I6	12.03	0.00	1.38	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	7.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	24.30	1.78	0.59	0.00	0.20	0.20	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	0.00	2.16	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	28.49	3.34	0.35	0.58	0.35	0.00	0.46	0.12
Lens Epithelial Cells, donor3	11690-122I7	25.53	4.54	0.81	1.01	0.71	0.10	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.86	2.37	1.66	0.36	0.47	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.37	2.51	0.28	0.00	0.28	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.12	4.72	2.52	1.10	1.42	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.68	1.61	0.00	0.00	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.04	0.00	0.63	0.63	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.61	1.62	0.86	0.54	0.32	0.11	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.18	2.87	1.64	0.41	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.54	0.51	0.51	0.00	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.88	1.69	1.27	0.14	0.28	0.42	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	10.28	3.16	0.79	0.00	0.40	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.11	1.74	0.97	0.58	0.39	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.89	0.93	0.74	0.19	0.37	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.76	4.18	0.35	0.35	0.35	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.39	1.67	0.72	0.72	0.00	0.72	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.46	1.24	0.96	0.14	0.55	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.01	2.46	1.23	0.92	0.31	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.74	1.87	0.31	0.31	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.59	2.38	1.46	0.18	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.20	1.97	1.65	0.33	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.69	0.59	0.00	0.59	0.59	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.97	1.74	1.24	0.25	0.00	0.00	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	12.61	2.42	1.45	0.00	0.48	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	10.50	1.35	0.27	0.81	0.27	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.02	2.72	1.36	0.45	0.45	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.81	2.07	0.00	0.52	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.89	3.77	0.21	0.84	0.42	0.63	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.77	1.65	0.60	0.30	0.30	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	2.06	1.38	0.00	1.38	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.09	1.32	0.38	0.00	0.56	0.00	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.82	1.59	0.95	0.11	0.53	0.11	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.15	0.97	0.00	0.48	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.62	0.66	0.00	0.33	0.00	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.09	1.61	0.99	0.00	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	16.66	5.92	2.59	1.11	1.48	0.74	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.40	1.48	0.74	0.25	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.95	1.10	0.55	0.00	0.41	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.90	3.22	0.96	0.96	0.96	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	16.13	3.96	1.83	1.52	0.91	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	10.64	3.36	2.80	0.28	0.28	0.00	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.44	1.78	2.49	0.00	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	0.97	1.45	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.42	1.09	1.24	0.31	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.24	1.43	1.43	0.72	0.36	0.72	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.90	2.29	1.31	0.65	0.65	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.12	1.18	0.71	0.24	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	10.89	2.10	0.99	0.25	1.24	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.15	1.02	0.26	0.26	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.27	2.09	0.60	0.30	0.60	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	0.00	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	17.64	1.53	0.77	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.13	1.48	0.00	0.00	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	23.27	1.27	1.27	0.85	0.42	0.85	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.29	0.00	1.41	1.41	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	11.21	0.00	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	17.00	1.55	0.52	0.52	0.00	0.52	0.52	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	20.22	5.95	1.19	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.17	2.04	1.13	0.00	0.00	0.68	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	26.17	0.87	1.16	0.29	0.29	0.87	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	23.86	2.25	1.35	0.90	0.00	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	25.06	1.49	1.08	0.68	0.68	0.27	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.00	1.03	0.51	1.03	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	19.41	3.88	1.41	0.71	0.35	0.00	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.32	0.67	1.33	1.33	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.00	1.53	0.51	0.00	1.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	21.34	2.13	1.33	0.80	0.53	0.27	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	23.62	1.51	1.51	0.76	0.00	0.94	0.38	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.16	1.84	0.61	1.23	0.00	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	25.28	0.82	2.45	0.82	0.82	0.82	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	22.70	1.87	0.62	0.62	0.42	0.42	0.83	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	21.86	1.40	0.56	1.12	0.56	1.12	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	23.70	2.06	1.03	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.16	1.45	0.58	0.58	0.00	0.29	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	19.73	0.60	1.20	0.30	0.60	0.30	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	19.36	1.66	2.21	1.11	1.11	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	24.04	2.12	1.06	0.71	0.00	0.00	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.18	2.58	0.00	1.84	0.37	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	16.12	1.15	0.00	1.15	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	24.56	1.92	0.00	0.77	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.12	1.70	0.57	0.57	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	21.33	2.46	0.00	0.82	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	17.17	0.45	0.90	0.00	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.24	0.72	0.72	1.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	25.39	2.24	1.49	0.00	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.21	1.49	0.37	0.74	0.37	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	17.66	1.72	0.00	0.43	0.00	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.98	0.00	0.86	1.71	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	23.32	1.33	1.67	0.33	0.00	0.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	1.81	1.21	0.00	0.00	1.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	21.33	0.71	0.71	0.00	0.00	2.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	23.72	0.69	0.34	1.37	0.00	1.03	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	23.08	3.22	0.54	0.00	0.54	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	18.85	0.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	23.71	0.74	1.11	0.00	0.00	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	9.30	1.16	3.49	1.16	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	27.50	0.00	0.00	0.00	1.06	2.12	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	22.41	1.20	2.40	0.00	0.80	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	21.08	1.45	0.73	2.18	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.93	0.77	1.53	0.00	0.77	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	22.69	0.99	0.99	0.99	0.00	0.99	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	24.46	0.00	0.94	0.00	0.94	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	26.65	2.01	3.02	0.50	0.00	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	24.33	2.25	1.80	1.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	0.00	0.00	5.16	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	30.73	2.23	0.00	0.00	0.89	0.89	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	23.46	1.96	1.56	0.39	0.00	1.17	1.17	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.07	1.98	1.98	0.66	0.00	0.00	0.66	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	31.65	1.04	1.56	2.08	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	25.38	1.75	0.88	1.31	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	21.80	1.12	1.68	1.12	0.00	1.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.06	1.77	0.88	1.32	0.44	0.44	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	27.39	0.77	0.00	0.39	1.16	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	19.75	1.01	1.01	1.52	0.00	1.52	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	18.74	1.92	0.48	0.96	1.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.66	2.39	1.19	0.40	0.00	1.59	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	21.87	1.82	0.00	1.22	0.61	1.22	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	23.52	0.00	1.38	0.00	0.69	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	28.88	1.52	0.76	0.00	0.00	0.38	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	23.24	1.55	1.55	1.55	0.52	2.07	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	24.79	3.02	1.81	0.00	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	22.50	1.27	2.22	1.58	0.00	0.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.66	2.13	1.07	0.53	0.00	1.07	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	19.54	2.87	0.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	23.65	0.51	0.51	0.51	0.00	1.54	0.00	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	0.00	1.41	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	26.67	2.27	0.57	0.00	0.57	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.14	0.83	1.25	0.83	0.00	0.00	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	19.58	1.57	0.78	1.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	18.79	0.84	1.25	0.00	0.42	0.84	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	21.37	0.93	1.86	1.39	0.46	0.00	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.74	1.34	2.68	0.67	2.01	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	25.66	3.74	2.67	0.53	0.53	2.14	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	15.36	2.83	1.62	0.00	0.00	1.21	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14.68	0.00	0.00	0.00	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	32.90	3.56	2.67	2.67	0.00	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	25.64	5.13	1.14	2.28	1.14	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.87	3.07	1.53	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	27.91	1.64	1.64	1.09	0.55	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.48	0.45	1.78	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	19.50	1.30	0.52	0.52	0.26	0.26	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	28.51	1.99	2.65	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	2.08	0.00	0.00	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	67.69	38.75	10.48	3.87	5.24	2.05	2.73	1.14
Macrophage - monocyte derived, donor2	11313-117C8	40.56	8.62	3.12	1.28	2.20	0.55	0.92	0.00
Macrophage - monocyte derived, donor3	11389-118C3	42.99	7.34	6.95	0.79	1.97	1.18	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	10.09	3.19	1.06	0.00	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	19.81	3.17	1.27	0.63	0.48	0.32	0.16	0.16
Mallassez-derived cells, donor3	11930-125I4	19.32	4.03	0.97	0.14	0.28	0.14	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	37.67	3.39	1.40	0.60	0.20	0.10	0.20	0.00
Mammary Epithelial Cell, donor2	11350-117G9	26.35	4.63	1.16	0.00	0.29	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	6.49	0.50	0.50	0.00	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	73.22	34.57	14.24	5.42	4.75	0.00	2.71	1.36
Mast cell, donor1	11563-120D6	55.04	6.06	2.81	1.84	1.95	0.22	0.54	0.22
Mast cell, donor2	11565-120D8	84.10	15.45	7.43	4.16	4.46	0.59	1.78	0.00
Mast cell, donor3	11566-120D9	138.00	18.91	8.55	4.73	2.93	0.68	0.45	0.00
Mast cell, donor4	11567-120E1	92.19	10.64	7.62	3.19	4.25	0.18	0.71	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	58.88	4.44	6.43	0.89	2.55	0.33	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	50.78	10.51	5.25	1.17	4.09	0.58	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	45.43	4.59	6.42	0.69	3.10	0.80	0.23	0.11
Mast cell, expanded, donor8	11941-126A6	49.54	8.37	7.53	2.01	3.01	0.67	0.33	0.50
Melanocyte - dark, donor1	11502-119F8	18.31	4.48	0.70	0.90	0.99	0.10	0.99	0.00
Melanocyte - dark, donor2	11582-120F7	16.27	3.11	0.69	0.69	0.00	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	29.92	2.68	0.80	0.58	0.72	0.22	0.29	0.00
Melanocyte - light, donor1	11274-116H5	13.40	1.88	0.94	0.47	0.47	0.24	0.24	0.00
Melanocyte - light, donor2	11351-117H1	13.65	1.36	0.00	0.68	0.00	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	4.34	0.87	0.00	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	22.70	1.46	1.46	0.42	0.21	0.31	0.10	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	19.90	4.57	2.69	1.08	0.54	0.81	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	35.89	4.82	4.29	0.54	1.07	0.27	0.27	0.00
Meningeal Cells, donor1	11493-119E8	18.11	2.73	0.74	0.12	0.25	0.00	0.37	0.00
Meningeal Cells, donor2	11573-120E7	9.24	3.52	1.32	0.88	0.00	0.00	0.88	0.00
Meningeal Cells, donor3	11654-122E7	17.60	3.18	1.47	1.14	0.82	0.24	0.49	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	18.54	3.42	1.14	0.86	0.57	0.29	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	27.98	1.51	1.21	0.30	0.91	0.20	0.30	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	0.00	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	13.63	4.31	0.72	0.00	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	17.36	2.96	1.48	1.48	0.64	0.00	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.58	3.52	2.51	0.50	1.01	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.33	0.88	0.00	0.00	0.44	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	3.65	2.92	0.00	0.73	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.75	1.23	0.41	0.00	0.82	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	28.95	2.77	1.11	0.00	0.69	0.28	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.58	0.74	0.00	0.00	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	30.53	1.58	0.53	0.39	1.05	0.13	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.90	0.89	0.59	0.59	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.25	0.64	0.64	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	21.98	0.35	0.71	0.35	0.71	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.77	1.25	0.94	0.63	0.94	0.31	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.89	1.45	0.00	0.00	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	26.52	2.12	1.59	1.33	0.27	0.27	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	13.51	1.00	0.50	1.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	20.16	2.31	1.30	0.29	0.14	0.36	0.43	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	10.80	4.05	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	64.52	37.68	14.28	5.66	3.45	3.69	2.46	3.69
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	33.27	17.37	5.89	2.65	3.83	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	6.91	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	45.87	30.99	10.85	2.48	1.55	4.03	2.79	2.79
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	32.15	12.24	3.53	1.04	3.32	1.45	1.24	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	11.58	4.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	45.55	36.29	14.01	3.00	4.25	3.75	2.00	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	34.91	17.69	6.52	0.93	5.59	0.93	0.93	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	40.85	27.23	12.80	4.06	4.06	1.63	2.03	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	36.43	16.63	5.94	0.79	2.77	0.40	0.00	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	34.21	17.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	30.97	42.48	9.73	2.65	2.65	2.65	1.77	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	25.08	23.18	6.08	2.66	3.04	1.52	1.14	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	19.74	1.32	0.00	1.32	1.32	2.63	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	40.32	55.82	12.73	5.31	4.24	2.33	3.82	5.94
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	14.73	1.84	1.84	0.00	0.00	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	33.08	56.93	8.64	2.38	2.38	1.49	3.58	8.64
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	13.41	0.00	0.00	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	32.87	78.78	9.03	6.02	2.01	5.27	4.01	17.56
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	28.76	36.84	5.94	4.99	3.09	1.90	2.61	3.33
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.72	49.21	2.76	2.76	1.66	1.11	1.66	6.08
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	32.93	91.87	7.60	9.67	2.30	7.37	9.44	39.37
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	33.44	43.75	6.10	2.94	2.31	2.10	3.16	8.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	22.83	109.46	8.56	8.36	3.26	4.48	8.97	39.14
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	30.25	87.53	9.23	8.80	2.57	2.15	6.22	37.33
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.01	66.24	5.11	6.22	2.67	2.00	5.11	6.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	51.59	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	29.57	125.06	7.45	10.51	2.19	7.23	9.42	42.71
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.18	52.72	2.03	6.59	1.01	0.51	6.08	8.62
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	54.68	1.66	1.66	1.66	0.00	9.94	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	22.83	130.73	10.06	11.42	2.72	6.52	10.33	64.96
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	23.82	83.23	6.18	8.23	2.94	2.06	4.71	7.65
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	25.08	3.27	0.00	0.00	0.00	2.18	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	23.55	71.60	4.81	8.17	2.40	7.21	8.17	30.76
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	24.81	73.64	7.20	6.00	4.40	0.40	4.40	14.01
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	26.05	1.37	2.74	0.00	0.00	1.37	5.48
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	21.02	53.06	5.51	5.51	2.50	3.00	3.50	21.52
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	107.79	26.95	0.00	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	14.27	0.00	4.08	0.00	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	24.09	47.73	4.38	7.44	2.63	0.88	3.50	8.76
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	35.32	3.31	1.10	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.20	17.93	1.28	1.28	0.64	0.00	1.28	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	26.53	46.86	6.94	4.71	1.98	2.23	4.96	5.45
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	22.27	0.70	0.70	0.70	1.39	3.48	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	13.26	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	26.67	25.30	8.89	2.74	1.37	2.74	2.05	2.74
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	38.95	2.63	3.50	0.44	1.31	1.75	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.49	12.07	2.13	1.42	1.07	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	34.23	39.00	7.86	5.61	2.81	2.52	1.96	2.81
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	13.72	40.73	4.16	4.99	1.25	0.42	3.33	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.08	12.82	1.75	0.58	1.17	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	27.75	31.98	10.56	4.52	2.71	1.51	2.11	2.41
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	20.87	40.07	5.01	5.43	4.17	1.25	2.50	2.50
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	14.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	28.63	31.40	9.24	0.92	1.85	1.85	3.69	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	19.92	42.68	5.69	5.12	2.85	1.14	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	21.42	17.27	4.84	1.38	1.11	0.55	0.97	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	31.88	31.88	7.00	5.96	2.59	2.85	2.33	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.74	41.18	7.29	4.29	1.29	2.57	3.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	11.43	1.91	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	21.35	26.16	4.80	3.74	0.53	1.07	1.87	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	38.01	21.85	6.59	1.20	2.69	0.30	2.39	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	21.33	8.05	4.24	1.55	0.99	0.14	0.99	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	27.07	28.35	9.24	3.50	1.59	0.64	0.96	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	26.09	41.13	5.97	4.20	2.87	1.77	3.32	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.72	9.86	3.41	1.52	1.14	0.38	2.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	35.23	29.83	8.24	5.11	1.99	1.42	2.56	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	37.85	31.22	6.88	4.92	3.69	0.74	1.97	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	5.21	1.96	0.65	0.00	0.65	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	30.28	17.94	5.29	1.18	1.76	0.88	0.88	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	40.37	21.05	7.78	1.73	2.31	1.15	1.15	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	36.68	6.59	9.89	1.24	2.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	38.12	13.40	6.25	2.38	1.79	1.19	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	15.07	3.77	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	33.86	17.82	0.00	3.56	3.56	0.00	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	46.00	37.46	11.83	5.26	3.29	1.64	3.29	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	35.77	8.42	5.26	2.10	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	42.90	10.48	7.12	2.17	4.15	1.19	0.79	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.98	7.45	4.66	0.00	0.00	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	49.95	42.06	15.02	7.51	5.26	2.25	4.88	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	31.43	11.72	3.73	0.53	1.60	0.27	0.80	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	28.95	9.84	4.41	2.04	2.38	0.68	0.90	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	29.47	11.05	3.68	2.21	0.74	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	47.64	35.18	9.89	4.03	2.56	2.93	3.30	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	37.33	10.89	10.89	3.11	3.11	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	29.39	11.22	4.28	1.60	2.67	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	15.46	7.73	3.86	3.86	0.00	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	27.27	20.20	9.09	4.04	2.02	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	38.79	13.49	5.06	0.00	2.95	0.42	1.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	35.41	29.96	8.17	0.00	1.36	1.36	2.72	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	18.44	10.81	3.18	0.64	0.00	0.64	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.87	15.39	2.43	4.05	0.81	0.00	3.24	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	49.84	4.53	4.53	0.00	0.00	0.00	0.00	6.04
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	125.62	165.59	11.42	0.00	0.00	0.00	5.71	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	68.51	61.99	13.05	6.52	9.79	0.00	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	95.05	9.50	0.00	4.75	0.00	9.50	14.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	50.20	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	21.11	1.51	0.65	0.65	0.43	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	23.52	1.57	1.05	0.00	0.00	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.69	3.34	0.67	0.00	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.93	0.83	0.83	0.00	0.83	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.81	3.04	2.66	1.90	0.19	1.90	0.00	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	3.19	6.38	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.88	0.00	1.36	0.00	0.68	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	1.84	7.35	0.00	0.00	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.00	1.26	0.84	0.00	0.42	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	17.43	2.09	2.79	0.46	0.46	0.70	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	20.54	1.08	1.62	0.27	0.54	0.27	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	24.60	2.10	1.68	0.42	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	22.34	2.48	1.99	0.50	0.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	24.90	0.54	0.27	0.00	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	21.31	1.36	2.49	0.23	0.00	0.68	0.45	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.70	1.63	0.65	0.82	0.65	0.49	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	30.44	1.82	1.82	0.73	0.18	0.73	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	24.93	1.06	2.65	0.53	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	26.41	3.00	2.40	1.20	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	27.90	2.30	2.30	0.00	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.03	0.49	1.30	0.16	0.16	0.16	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	18.17	2.12	1.41	0.53	0.35	0.18	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	23.21	1.41	0.00	0.00	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	20.23	0.00	1.84	0.00	0.00	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	29.24	1.29	1.93	0.96	0.32	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	26.90	1.72	2.41	1.03	0.34	2.41	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	25.28	5.06	5.06	2.53	0.00	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	17.60	0.89	0.45	0.22	0.45	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.94	0.42	2.54	0.00	0.00	0.00	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.84	1.66	1.90	0.24	0.00	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.04	0.86	0.43	0.43	0.00	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	18.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	21.99	1.00	1.00	0.33	0.33	0.33	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	14.88	0.90	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.46	1.19	0.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	1.86	2.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	23.84	0.00	0.38	0.76	0.00	0.00	0.00	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.60	0.65	0.65	0.00	0.00	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.07	0.87	0.44	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.21	0.00	0.90	0.00	1.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	32.63	0.00	0.00	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.28	0.66	2.66	0.66	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	25.30	0.99	1.98	0.50	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.93	1.15	0.77	0.00	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	30.55	1.51	0.60	0.30	0.30	0.91	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	24.98	0.88	0.88	0.44	0.88	0.44	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.04	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	24.39	0.61	1.22	0.61	1.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.11	0.63	0.63	0.31	0.00	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.13	0.61	0.61	0.30	0.30	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	19.78	0.00	0.79	1.58	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	0.00	4.53	2.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	0.00	5.06	0.00	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	20.13	1.61	2.36	0.62	0.62	0.50	0.25	0.12
Myoblast, donor2	11322-117D8	33.18	2.69	4.22	0.38	1.15	0.58	0.00	0.19
Myoblast, donor3	11398-118D3	23.04	1.85	0.84	0.50	1.51	0.00	0.50	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	44.22	7.15	1.46	0.73	0.58	0.15	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	122.39	34.44	4.92	13.22	3.38	0.92	1.85	0.31
Natural Killer Cells, donor2	11311-117C6	106.15	32.87	16.59	13.87	4.52	3.62	0.90	0.30
Natural Killer Cells, donor3	11387-118C1	91.11	32.03	9.39	4.79	4.05	1.47	1.47	0.18
Neural stem cells, donor1	11275-116H6	37.75	1.81	2.18	2.54	2.54	0.00	1.09	0.00
Neural stem cells, donor2	11352-117H2	59.69	1.93	5.78	1.93	3.85	0.00	1.93	0.00
Neurons, donor1	11494-119E9	28.45	3.41	0.00	1.14	2.28	1.14	0.00	0.00
Neurons, donor2	11574-120E8	25.10	3.08	1.10	0.44	0.66	0.22	0.00	0.00
Neurons, donor3	11655-122E8	33.71	3.29	0.82	0.82	0.82	0.82	0.82	0.00
Neutrophils, donor1	11233-116C9	149.41	19.49	31.55	6.50	3.71	0.00	0.93	0.93
Neutrophils, donor2	11314-117C9	153.64	11.60	23.19	0.00	5.80	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	238.23	25.66	35.43	12.22	17.71	0.61	3.05	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	30.75	3.21	1.90	0.59	1.07	0.12	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	13.68	2.93	1.63	0.65	0.98	0.33	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	19.05	2.41	0.40	0.20	0.60	0.80	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	22.30	1.79	0.55	0.96	0.28	0.28	0.28	0.00
Olfactory epithelial cells, donor2	11934-125I8	30.98	1.01	2.46	1.01	0.29	0.58	0.29	0.87
Olfactory epithelial cells, donor3	11935-125I9	31.33	2.38	1.02	0.34	0.34	0.45	0.23	0.00
Olfactory epithelial cells, donor4	11936-126A1	32.14	1.75	2.14	0.39	0.10	0.19	0.39	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	27.08	3.01	0.60	0.60	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	17.23	0.43	0.21	0.21	0.43	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	0.00	2.29	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	10.55	1.86	0.62	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	5.08	0.98	0.39	0.20	0.20	0.20	0.20	0.00
Osteoblast, donor2	11354-117H4	16.86	4.92	0.70	0.00	2.11	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	14.22	2.84	1.78	0.53	0.71	0.18	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	29.74	1.68	1.01	0.76	0.76	0.17	0.08	0.00
Pericytes, donor1	11491-119E6	5.90	0.78	0.56	0.00	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	9.05	1.13	0.23	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	8.14	0.00	0.41	0.00	0.00	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	30.06	0.90	0.90	0.57	0.45	0.45	0.11	0.00
Perineurial Cells, donor2	11579-120F4	20.89	4.51	1.38	1.56	0.74	0.18	0.74	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	120.16	29.32	6.69	6.37	7.33	0.32	0.64	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	87.17	16.90	11.75	3.67	2.69	1.47	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	82.18	20.06	12.29	4.14	3.24	0.78	0.65	0.65
Placental Epithelial Cells, donor1	11278-116H9	10.04	1.67	0.00	0.24	0.24	0.48	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	15.52	4.44	0.00	1.11	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.03	1.18	0.59	0.20	0.00	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.66	0.32	1.27	0.63	0.32	0.63	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	26.83	1.50	0.75	0.56	0.75	0.19	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	42.42	1.57	1.57	0.52	0.52	0.13	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	18.46	0.90	1.80	0.45	0.00	0.68	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	24.51	1.39	1.28	0.21	0.64	0.32	0.32	0.00
Preadipocyte - omental, donor2	11329-117E6	32.30	3.06	0.44	0.87	0.44	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	19.91	1.15	0.29	0.29	0.43	0.43	0.43	0.14
Preadipocyte - perirenal, donor1	11469-119C2	9.84	0.00	0.98	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.36	0.61	0.61	0.61	0.31	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	21.60	2.83	3.36	0.89	0.89	0.89	0.18	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	17.54	1.02	1.53	1.36	0.34	0.34	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	26.64	4.47	2.14	1.30	1.02	0.00	0.09	0.09
Preadipocyte - visceral, donor2	11357-117H7	22.55	2.76	2.30	0.46	1.84	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	23.51	2.51	1.46	0.73	0.52	0.94	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	27.15	8.30	1.36	2.72	0.75	0.30	0.91	0.15
Prostate Epithelial Cells, donor2	11331-117E8	17.87	1.35	1.49	0.68	0.41	0.27	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	27.01	0.49	0.73	0.24	0.43	0.06	0.00	0.06
Prostate Stromal Cells, donor1	11254-116F3	16.74	1.14	0.91	0.00	0.57	0.34	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	22.59	1.43	1.79	0.00	0.36	0.36	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	25.86	1.25	1.56	0.52	0.83	1.25	0.10	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.57	0.73	0.36	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	25.44	3.74	1.94	0.69	0.49	0.14	0.28	0.00
Renal Epithelial Cells, donor1	11517-119H5	6.59	2.03	0.51	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	1.42	0.00	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	28.37	4.66	2.12	0.95	1.16	0.00	0.42	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	0.68	1.36	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.89	2.83	0.67	0.54	0.27	0.27	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.99	5.33	2.00	1.78	0.67	1.11	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	1.33	2.00	1.33	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.94	3.08	0.00	0.22	0.44	0.00	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	8.15	0.63	0.63	0.00	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.22	1.66	0.00	0.28	0.00	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.62	1.34	0.54	0.27	0.27	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	7.59	0.84	0.42	0.42	0.00	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.17	1.54	0.39	0.19	0.00	0.39	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	25.15	2.85	0.26	0.00	0.78	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	8.53	3.13	0.00	0.57	0.00	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	13.05	2.01	0.00	0.75	0.75	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	64.55	4.14	2.67	0.53	1.74	0.00	0.13	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	17.87	0.00	1.79	0.00	0.00	1.79	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	58.34	3.85	6.60	0.00	1.10	0.55	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	24.36	1.16	3.48	0.00	2.32	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	25.35	5.59	2.86	0.52	0.91	0.00	0.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	20.16	2.18	2.38	0.60	0.50	0.50	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	25.99	4.24	1.23	1.00	0.89	0.33	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	28.90	2.60	2.11	0.74	0.50	0.25	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.41	1.98	1.52	0.23	1.05	0.35	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	31.43	2.77	2.31	1.16	0.23	1.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	24.64	2.33	2.46	0.00	0.68	0.00	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	21.03	1.82	1.21	0.45	0.45	0.15	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	22.58	3.05	1.08	0.72	0.72	0.00	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	26.40	4.02	2.73	0.57	0.43	0.14	0.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.67	1.61	1.61	0.21	0.32	0.75	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	27.44	2.88	2.21	1.55	0.89	0.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	24.28	1.15	3.06	0.38	0.38	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.05	2.52	2.33	0.28	0.65	0.56	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	28.37	3.38	2.82	1.32	1.50	0.00	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	24.15	2.39	1.73	0.66	0.40	0.00	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	22.39	1.46	2.14	0.49	0.10	0.19	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	25.97	2.67	1.91	0.38	0.38	0.00	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	27.34	1.39	1.71	0.21	0.32	0.32	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	17.10	2.52	0.84	0.00	0.28	1.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	22.90	2.73	1.88	0.68	0.34	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	23.52	3.28	1.09	0.00	0.55	0.36	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	22.69	2.45	1.96	0.25	0.49	0.49	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	23.51	4.16	1.48	0.27	0.54	0.67	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	32.31	3.30	3.07	0.24	1.42	0.00	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	22.82	1.59	2.38	0.20	0.60	0.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	28.76	0.94	1.87	0.70	0.47	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	23.85	2.90	1.87	0.41	0.62	0.62	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.91	1.11	2.43	0.22	0.88	0.44	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	20.68	1.46	1.67	0.42	0.42	0.63	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	27.19	2.15	2.02	0.67	0.81	0.27	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	20.61	1.87	1.19	0.51	0.51	0.17	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.83	4.43	1.93	0.77	0.39	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	23.90	1.89	1.89	0.52	0.86	0.34	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	21.40	2.47	1.65	0.41	0.69	0.41	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	21.67	4.10	2.63	0.66	0.49	0.82	0.33	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	20.45	4.26	1.36	0.51	0.00	0.17	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	20.57	2.52	1.63	0.89	0.00	0.15	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	19.46	2.40	4.00	0.27	0.53	0.27	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	29.59	2.90	1.80	0.41	0.41	0.28	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	19.29	2.14	2.14	0.95	0.71	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	28.62	4.23	2.82	0.20	0.60	0.40	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	23.26	3.20	1.51	0.47	0.66	0.47	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	20.26	3.14	2.79	0.35	1.05	0.35	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	22.36	3.02	1.21	0.60	0.60	0.60	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	24.84	2.94	1.96	0.24	0.49	0.24	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	66.81	10.77	5.09	1.75	2.62	0.44	0.29	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	29.81	2.43	1.22	0.00	0.00	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	24.71	3.92	3.32	0.60	1.21	0.00	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	24.43	1.13	1.81	0.00	1.36	0.23	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	36.84	3.00	2.70	0.00	0.30	1.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	29.52	5.08	2.01	0.59	1.65	0.47	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	19.85	2.56	2.35	0.64	3.84	0.43	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	26.44	2.40	3.61	0.00	2.40	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	7.90	0.38	0.38	0.00	0.19	0.19	0.19	0.00
Schwann Cells, donor2	11578-120F3	10.21	0.00	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	12.27	2.41	1.75	0.44	0.44	0.88	0.44	0.22
Sebocyte, donor1	11220-116B5	20.27	4.93	0.00	0.55	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	12.87	1.38	1.38	0.00	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	9.48	0.41	0.41	0.00	0.21	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	24.85	1.66	0.00	3.31	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	2.82	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	27.54	1.76	0.53	0.35	0.18	0.00	0.00	0.00
Skeletal Muscle Cells, donor2	11358-117H8	5.06	0.72	0.00	0.72	0.72	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	11.70	0.84	0.84	0.00	0.00	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	27.96	2.20	1.73	0.31	0.31	0.63	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	23.63	1.93	2.08	1.04	0.89	0.30	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	34.17	3.39	0.77	0.00	0.62	1.08	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	39.31	2.14	2.27	0.63	0.76	0.50	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.39	3.00	2.00	0.43	0.86	0.29	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	25.70	2.78	1.59	0.79	0.79	0.20	0.20	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.40	2.02	0.76	0.25	0.84	0.00	0.42	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.13	0.72	0.72	0.72	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.87	1.65	1.38	0.28	0.14	0.55	0.00	0.41
Skin - palm, donor1	10286-104F7	37.61	0.00	0.00	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.78	1.15	1.01	0.29	0.00	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	98.15	27.81	9.00	3.27	0.82	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.42	1.82	0.91	0.13	0.39	0.26	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	25.58	1.81	1.25	0.56	0.56	0.14	0.28	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	22.36	2.39	2.25	0.42	0.70	0.70	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	96.42	12.90	3.59	2.11	3.17	1.06	0.21	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	21.96	0.60	0.82	0.07	0.22	0.52	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	18.21	1.85	0.62	0.62	0.31	0.62	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	41.13	3.56	0.89	0.67	0.67	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	13.52	2.35	0.59	0.00	0.00	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11.71	1.33	1.10	0.00	0.44	0.00	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.51	1.18	0.39	0.79	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.77	1.55	0.00	0.00	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	1.00	2.00	1.00	1.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.71	1.20	0.40	0.40	0.40	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	22.17	1.77	2.22	0.44	0.44	0.44	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.11	3.84	1.02	0.38	0.51	0.26	0.38	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.23	2.93	0.98	0.65	0.65	0.33	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	23.92	5.02	1.48	1.48	0.89	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.94	1.42	1.42	0.43	0.28	0.28	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	34.71	1.52	2.13	0.61	0.30	1.22	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	13.89	0.76	0.00	0.00	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.54	0.95	0.48	0.00	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.69	2.06	1.47	0.59	0.44	0.29	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	19.37	3.01	2.15	0.43	0.43	1.08	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	22.46	3.04	1.99	0.31	0.21	0.42	0.52	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.12	1.08	0.93	0.00	0.15	0.00	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	0.00	0.00	0.00	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.36	1.79	0.90	0.30	0.60	0.30	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.80	0.34	0.34	0.68	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	32.75	2.12	1.18	0.24	0.55	0.16	0.16	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.43	1.21	1.11	0.91	0.70	0.50	0.10	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	23.67	5.46	3.41	1.82	1.37	0.91	1.59	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.85	0.60	0.60	0.60	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	32.32	2.38	2.38	0.53	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	31.29	2.00	0.93	0.67	0.80	0.13	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	24.04	1.50	1.13	0.88	0.50	0.50	0.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.02	2.03	0.25	0.51	0.76	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.17	2.26	1.06	0.30	0.15	0.00	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	0.00	0.75	0.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	2.58	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	14.42	1.40	0.47	0.47	1.40	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	0.50	1.01	0.50	0.50	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.04	1.57	1.57	0.31	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.90	0.29	0.00	0.00	0.00	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	20.99	2.42	0.58	0.42	1.00	0.25	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	19.15	0.47	1.40	0.47	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.49	1.01	1.01	0.29	0.00	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.98	2.29	2.29	0.76	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.71	0.94	0.75	0.19	0.38	0.38	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	25.71	1.54	0.56	0.84	0.14	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.38	1.76	0.25	0.17	0.25	0.08	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	8.56	0.98	0.49	0.24	0.24	0.00	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	35.35	2.21	2.21	0.22	0.66	0.22	0.66	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	26.33	2.05	1.46	0.00	0.00	0.88	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	23.32	0.39	1.55	0.00	0.39	0.00	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	16.66	0.79	2.91	0.00	0.53	0.26	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	40.54	1.12	2.60	0.00	2.23	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	25.51	0.36	1.44	0.72	0.72	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	20.44	1.14	1.42	0.00	0.00	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	26.39	1.58	1.18	0.39	0.39	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	25.40	3.05	1.27	0.00	1.02	0.76	0.00	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	27.15	0.40	0.80	0.40	1.20	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	17.56	0.42	1.25	0.00	0.00	1.67	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	25.21	1.83	0.92	0.46	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	21.21	0.84	1.01	0.34	0.50	0.00	0.17	0.00
Synoviocyte, donor2	11368-117I9	19.95	1.17	1.68	1.01	0.67	0.34	0.00	0.17
Synoviocyte, donor3	11440-118H9	27.93	0.45	0.89	0.45	0.22	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	9.65	1.07	0.00	0.00	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	0.00	5.95	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.10	0.46	0.46	0.00	0.23	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	15.99	1.08	0.50	0.14	0.14	0.00	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	8.12	1.55	1.16	0.00	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	12.60	0.57	1.15	0.57	0.57	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	65.57	4.18	3.08	0.62	1.72	0.37	0.12	0.25
Urethra, donor2	10319-105A4	34.17	0.00	5.40	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	4.78	0.53	0.27	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.58	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	28.53	0.67	0.67	0.22	0.00	0.45	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	119.23	4.45	7.12	0.89	1.78	2.67	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	151.54	10.01	5.72	0.00	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	119.79	4.11	10.95	0.68	1.37	2.74	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	97.79	7.23	6.20	1.03	2.41	0.34	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	92.96	5.81	6.39	2.32	2.91	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	149.94	7.29	3.12	4.16	5.21	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	112.89	11.01	6.42	0.00	3.67	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	83.99	10.04	8.22	0.00	1.83	4.56	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	8.76	17.89	2.10	3.82	0.86	0.37	2.10	0.12
Wilms' tumor cell line:HFWT	10597-108E3	25.52	0.88	0.88	0.88	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	44.97	2.79	0.84	0.28	0.28	0.56	0.00	0.00
achilles tendon, donor2	10292-104G4	33.06	8.27	8.27	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	18.36	27.79	1.53	3.82	3.06	0.25	1.53	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	28.56	42.49	3.71	7.20	2.55	0.00	1.63	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	39.53	32.53	2.37	7.60	2.14	0.12	2.02	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	18.50	25.85	2.18	4.63	2.45	0.00	2.18	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	21.08	36.26	6.75	7.87	1.97	1.69	3.09	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	35.53	26.01	5.08	2.54	3.17	0.21	0.85	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.83	29.40	7.89	3.27	2.99	1.91	1.09	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	31.29	33.05	5.29	0.88	3.53	0.88	2.20	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	26.54	25.32	8.58	3.68	4.90	0.82	1.63	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	42.71	22.13	5.82	5.05	5.82	0.39	1.94	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	27.23	20.61	7.36	3.31	2.39	0.92	0.92	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	66.31	27.30	11.70	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	13.48	51.82	5.11	11.62	3.49	1.16	3.72	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	54.11	14.24	7.25	0.78	4.40	0.52	0.26	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	42.67	9.35	7.60	2.05	2.05	0.29	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	39.97	17.20	6.97	0.93	4.65	0.00	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	61.69	7.40	7.40	0.41	2.47	0.00	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	47.27	15.96	10.44	1.23	4.30	0.00	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	77.23	16.21	14.51	1.71	4.27	1.71	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	74.61	19.41	8.19	3.34	3.03	0.91	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	83.77	22.39	15.89	5.05	5.54	1.20	2.41	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	28.51	4.45	5.35	0.45	2.45	0.67	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	28.02	4.67	2.00	0.33	0.67	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	14.87	0.00	3.72	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	9.42	16.20	2.26	2.26	0.75	0.75	1.13	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	11.78	10.03	1.74	1.31	1.31	1.31	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	29.99	0.00	5.62	0.00	0.00	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	52.99	0.47	0.24	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	45.14	4.81	4.65	0.31	1.40	0.16	0.78	0.47
adipose, donor1	10184-103D4	29.91	22.87	1.17	4.69	0.59	3.52	2.35	0.59
adipose, donor2	10185-103D5	45.82	7.70	0.41	1.62	0.41	0.41	0.41	0.81
adipose, donor3	10186-103D6	22.33	5.45	1.09	1.63	0.00	0.54	0.82	0.00
adipose, donor4	10187-103D7	20.80	9.53	1.73	1.73	0.00	0.87	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.05	4.73	1.10	1.26	0.47	0.00	0.79	0.00
adrenal gland, adult, pool1	10081-102A9	21.83	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	40.56	2.80	1.33	0.13	0.80	0.00	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	48.59	8.22	2.14	2.50	1.43	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	37.33	1.39	1.16	0.00	0.23	0.93	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	37.87	1.69	0.34	0.68	0.68	0.34	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	60.10	1.18	1.18	0.59	0.29	1.18	0.00	0.00
amygdala - adult, donor10196	10167-103B5	39.13	2.37	4.74	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	51.10	2.64	2.23	0.41	0.41	0.41	0.20	0.41
amygdala, newborn, donor10223	10360-105E9	27.11	3.23	2.90	1.29	0.65	0.32	0.00	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	42.91	3.44	0.64	0.13	0.25	0.13	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	38.17	5.74	1.54	0.88	0.88	0.00	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	58.12	22.05	1.67	7.01	2.00	0.00	2.00	0.00
aorta, adult, pool1	10052-101G7	49.62	3.53	2.75	0.39	0.78	1.37	0.00	0.20
appendix, adult	10189-103D9	104.79	11.64	7.37	3.10	3.88	1.94	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	40.24	4.13	0.69	0.69	0.34	0.34	0.34	0.00
artery, adult	10190-103E1	38.04	0.00	2.72	0.00	1.36	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	42.74	20.14	2.75	5.50	2.03	0.43	2.03	0.29
b cell line:RPMI1788	10427-106D4	44.61	18.29	3.27	3.42	1.78	0.15	1.04	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	31.91	2.22	1.11	0.28	0.55	0.28	0.83	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	38.70	2.28	0.99	0.40	0.40	0.10	0.00	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	48.20	0.50	0.50	0.17	0.33	0.17	0.50	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	65.43	2.80	8.95	1.12	1.12	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	54.10	1.74	2.17	0.65	0.98	0.11	0.22	0.11
blood, adult, pool1	10053-101G8	84.16	4.43	2.21	2.21	4.43	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	1.71	0.86	0.00	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	53.31	8.77	4.72	0.67	3.37	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	39.98	1.03	1.03	0.00	0.00	1.03	0.00	2.05
brain, adult, pool1	10012-101C3	39.98	1.78	1.45	0.56	0.56	0.11	0.33	0.45
brain, fetal, pool1	10085-102B4	34.73	0.00	5.34	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	44.27	0.66	0.99	0.99	0.66	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	52.18	2.37	1.50	0.62	0.87	0.12	0.37	0.00
breast, adult, donor1	10080-102A8	43.56	2.53	1.26	0.63	1.89	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	36.84	3.94	0.89	0.64	0.38	0.76	0.25	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	34.32	3.71	0.31	0.31	0.31	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	25.32	4.14	0.69	2.30	0.46	0.92	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	25.66	3.39	1.21	0.00	0.24	0.24	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	42.79	3.29	0.94	0.94	0.00	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	19.25	1.31	0.88	0.00	0.11	0.44	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	34.22	31.06	2.54	3.17	1.27	0.63	2.22	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	61.22	11.45	3.73	2.66	1.86	2.40	1.33	0.27
caudate nucleus - adult, donor10196	10177-103C6	93.26	3.45	3.45	0.00	0.00	1.15	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	63.92	2.34	2.34	0.50	0.33	0.50	0.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	61.13	2.29	0.00	1.53	3.82	0.76	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	43.58	5.49	3.30	0.73	0.73	2.20	0.00	3.30
cerebellum - adult, donor10196	10173-103C2	151.49	0.00	5.83	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	84.55	2.14	4.70	0.21	0.64	0.21	0.21	0.00
cerebellum, adult, pool1	10083-102B2	58.30	0.34	1.03	0.00	0.00	1.03	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	63.93	0.83	6.64	0.00	1.66	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	42.86	3.03	2.52	0.50	0.76	0.00	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	20.46	2.92	2.92	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	39.11	2.16	0.86	0.43	0.58	0.00	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	50.21	7.13	0.83	1.49	0.50	0.66	0.66	0.00
cervix, adult, pool1	10013-101C4	75.59	2.41	4.83	1.78	2.41	0.21	0.31	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	42.64	1.25	1.39	0.14	0.28	0.00	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	1.31	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	59.03	15.53	2.61	1.86	1.86	0.25	0.37	0.37
choriocarcinoma cell line:SCH	10785-110H2	25.38	8.75	0.99	0.86	0.37	0.12	0.37	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	47.91	6.88	0.47	1.19	0.00	0.47	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	37.89	3.99	1.71	0.57	0.85	0.85	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	25.06	4.37	1.39	0.99	0.89	0.40	0.70	0.10
chorionic membrane cells, donor3	12240-129G8	53.85	3.85	4.40	0.00	2.20	0.55	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	15.15	2.02	2.02	0.00	2.02	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	29.58	14.41	3.65	4.03	1.15	0.00	1.15	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	25.76	23.02	3.38	6.34	2.96	0.63	3.38	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	40.06	19.26	4.62	2.82	1.54	2.05	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	44.99	24.91	4.60	5.08	0.48	0.73	0.97	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	43.17	16.29	3.87	2.85	1.63	0.81	1.43	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	59.19	15.31	1.77	3.53	1.47	0.88	1.77	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	42.48	34.14	5.21	8.60	4.95	0.00	5.21	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	20.57	4.11	1.83	0.46	0.69	1.14	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	23.77	1.39	0.17	0.35	0.00	0.00	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	18.67	17.21	0.73	4.94	1.46	0.00	2.56	0.00
colon carcinoma cell line:COLO-320	10420-106C6	58.53	23.95	1.90	4.56	1.52	0.00	1.52	0.00
colon, adult, donor1	10082-102B1	61.88	4.76	4.76	0.00	0.00	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	69.80	2.23	1.88	0.59	2.23	0.35	0.12	0.00
colon, fetal, donor1	10070-101I7	112.47	3.09	2.47	0.62	1.85	1.85	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	50.42	59.59	4.58	9.17	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	89.66	34.42	4.67	8.07	2.55	0.85	4.25	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	25.81	13.58	2.26	3.92	3.47	0.00	1.06	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	27.07	18.05	2.40	4.37	3.24	0.14	2.12	0.14
corpus callosum, adult, pool1	10042-101F6	97.18	2.10	2.21	0.55	1.33	0.33	0.11	0.33
cruciate ligament, donor2	10295-104G7	51.06	3.24	4.86	1.62	1.62	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	32.10	4.01	2.41	2.41	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	43.68	1.20	2.40	0.48	0.72	0.48	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	23.42	30.08	5.28	5.51	2.53	2.07	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	41.29	5.13	0.77	0.26	0.77	0.51	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	31.78	12.76	0.48	2.17	0.24	0.00	1.69	0.24
ductus deferens, adult	10196-103E7	65.78	1.00	2.99	0.50	1.99	0.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	76.33	1.44	4.32	0.00	1.44	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	66.94	6.62	4.41	2.21	1.47	1.47	0.00	0.74
dura mater, adult, donor1	10041-101F5	89.44	15.11	5.20	2.89	2.23	0.17	0.50	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	22.65	44.86	3.55	6.00	1.33	0.67	3.78	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.05	16.48	1.00	2.29	0.57	0.29	0.72	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	7.40	1.85	0.00	1.23	0.00	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	23.01	2.42	0.91	0.00	0.00	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	24.39	2.16	0.62	0.93	0.31	1.23	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	14.45	1.31	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	22.79	13.07	0.67	3.02	0.67	0.00	1.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	40.78	3.44	1.09	0.36	0.54	0.00	0.72	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.48	4.02	1.13	0.00	0.64	0.80	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	41.13	2.78	1.22	0.56	0.33	0.22	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	26.62	0.88	0.88	0.44	0.11	0.11	0.22	0.00
epididymis, adult	10197-103E8	73.89	3.56	5.44	1.47	3.35	0.42	0.00	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	30.87	3.90	1.60	1.60	0.53	0.35	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.19	14.16	0.39	5.11	1.18	0.00	1.97	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	26.87	5.64	2.23	0.66	0.79	0.52	0.66	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	31.20	5.41	3.35	1.08	0.79	0.59	0.20	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	24.65	4.26	2.58	0.56	0.56	0.34	0.22	0.11
esophagus, adult, pool1	10015-101C6	51.28	1.81	2.55	0.00	1.49	0.42	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	33.06	13.40	3.26	6.26	1.50	0.25	2.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	74.85	7.24	2.41	0.00	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	4.21	2.10	0.00	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	20.84	1.49	1.49	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	22.93	3.44	0.00	2.29	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	21.86	8.74	1.46	1.46	0.00	0.00	2.91	0.00
eye, fetal, donor1	10054-101G9	33.56	1.53	1.27	0.51	0.00	0.51	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	37.19	4.49	1.67	0.64	0.26	0.13	0.38	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.78	2.85	1.42	0.24	0.47	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	63.24	3.00	1.31	1.22	0.56	0.38	0.19	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	43.84	8.11	1.80	1.20	0.90	0.00	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	57.97	0.91	1.65	0.27	0.46	0.27	0.27	0.00
gall bladder, adult	10198-103E9	61.81	2.17	2.66	1.69	1.45	0.24	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	92.88	10.20	9.66	1.07	1.07	2.15	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	85.90	13.07	8.59	2.24	2.24	0.75	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	43.30	4.65	2.75	1.90	0.63	0.42	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	58.60	3.09	1.74	0.19	0.19	0.39	0.00	0.58
gastric cancer cell line:AZ521	10549-107H9	26.40	16.07	3.28	6.07	0.49	0.16	1.64	0.16
gastric cancer cell line:GSS	10560-108A2	32.03	0.92	0.00	0.92	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	65.34	4.80	2.51	0.46	0.91	1.60	0.23	0.46
giant cell carcinoma cell line:LU65	10487-107B1	26.85	1.15	0.69	0.34	0.34	0.00	0.11	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	44.79	2.80	0.42	0.42	0.14	0.14	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	29.68	2.24	1.75	0.75	0.25	0.25	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	36.10	6.76	1.37	1.48	1.06	0.42	0.32	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	38.90	5.06	1.26	0.84	1.26	0.00	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	38.30	4.75	1.55	1.43	1.32	0.00	0.66	0.00
glioma cell line:GI-1	10413-106B8	57.70	5.86	3.51	0.88	0.29	0.29	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	47.38	4.37	2.92	0.00	1.46	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	86.17	2.20	3.42	0.24	0.49	1.22	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	49.29	0.00	0.00	0.00	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	33.57	2.13	2.13	0.53	2.13	1.60	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	48.94	44.05	2.45	9.79	4.89	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	10.93	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.00	1.92	1.28	0.32	0.00	0.32	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	14.69	22.04	2.30	2.30	1.38	1.38	0.92	0.92
hIPS +CCl2, biol_rep2	14384-156C1	16.00	22.41	0.91	3.20	0.46	1.37	1.83	0.00
hIPS +CCl2, biol_rep3	14385-156C2	7.09	17.39	0.64	3.86	0.00	0.00	1.29	0.00
hIPS, biol_rep1	14380-156B6	2.87	14.37	1.44	1.44	0.00	2.87	4.31	0.00
hIPS, biol_rep2	14381-156B7	8.92	18.52	1.37	4.12	0.00	1.37	1.37	0.00
hIPS, biol_rep3	14382-156B8	43.04	3.31	0.00	1.10	1.10	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	27.58	13.22	1.15	1.72	1.15	0.57	0.57	0.57
heart - mitral valve, adult	10205-103F7	42.45	2.69	2.99	0.60	0.90	0.60	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	46.54	2.88	2.35	0.26	1.83	0.52	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	52.46	1.67	4.16	0.00	1.67	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	35.51	1.63	0.61	0.41	0.00	1.02	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	30.23	3.41	2.13	0.85	0.43	1.28	0.00	0.00
heart, adult, pool1	10016-101C7	31.28	1.15	0.23	0.69	0.00	0.23	0.23	0.46
heart, fetal, pool1	10046-101G1	61.71	2.67	1.95	0.82	1.44	0.41	0.31	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	25.92	0.93	0.62	0.31	0.00	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	15.46	5.95	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	17.68	17.68	1.55	3.76	0.66	0.99	2.76	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	16.63	15.90	2.18	3.88	0.97	0.85	2.06	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	20.11	17.18	1.92	3.94	0.71	0.81	2.53	0.10
hepatoma cell line:Li-7	10484-107A7	25.58	5.12	0.56	0.89	0.67	0.22	0.22	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	24.32	17.59	1.81	2.21	0.90	0.20	0.60	0.00
hippocampus - adult, donor10196	10169-103B7	54.89	0.95	4.73	0.00	0.00	0.95	0.00	1.89
hippocampus, adult, donor10252	10153-102I9	62.86	2.04	2.65	0.61	0.20	0.61	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	29.38	4.48	1.49	1.99	0.00	0.50	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	37.36	1.41	2.11	0.35	0.00	0.70	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	17.09	15.26	1.22	5.49	0.61	1.83	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	19.83	9.23	0.98	1.37	0.79	0.59	0.59	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	20.06	10.41	1.78	2.29	0.51	0.76	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	21.43	19.17	2.82	2.26	0.56	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	28.92	16.01	1.81	3.10	1.29	3.36	2.07	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	24.30	16.32	2.66	3.04	1.14	1.52	1.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	29.49	7.01	2.63	2.92	1.75	1.17	0.88	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	34.90	10.34	2.59	1.94	1.72	0.65	0.65	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.85	11.68	3.34	2.50	0.83	0.00	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.65	6.63	2.13	1.18	1.18	0.47	0.95	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.95	4.34	1.61	2.09	0.32	0.64	0.32	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.91	6.73	1.35	2.69	2.02	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	14.55	9.23	0.31	2.03	0.78	0.63	1.41	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	20.63	5.90	1.47	0.98	0.49	3.44	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	19.20	10.47	0.87	1.75	0.00	1.75	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	35.70	20.24	2.29	4.96	1.34	1.15	0.19	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	28.78	17.88	0.87	4.80	1.74	0.00	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.99	24.99	1.50	7.00	2.00	3.50	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	55.01	10.55	1.70	1.70	0.75	1.70	0.75	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	54.11	11.37	2.73	1.82	0.45	0.45	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.84	9.40	2.19	1.57	1.25	0.63	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.23	6.04	1.63	1.47	1.14	0.16	0.49	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.39	4.06	2.03	1.16	0.58	0.29	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.92	3.89	2.39	0.60	0.60	0.60	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	19.77	11.08	1.48	2.40	0.74	0.92	0.55	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	16.83	9.98	2.57	1.71	0.86	1.14	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	21.23	18.37	2.04	2.86	0.41	0.82	2.45	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	26.41	14.44	3.17	3.17	1.06	2.46	2.11	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	22.81	10.14	1.58	4.12	0.95	0.95	1.58	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	23.91	9.38	1.82	1.82	1.21	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	32.58	9.31	1.03	2.07	0.00	1.03	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	26.57	13.95	1.99	1.99	0.00	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	16.16	8.21	1.03	1.54	0.26	0.77	1.28	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.87	4.35	2.56	2.30	0.51	1.79	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	25.75	9.09	2.27	1.51	3.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.48	5.38	2.02	1.34	0.34	1.34	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	14.49	11.35	0.72	3.14	1.21	0.72	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	21.39	12.48	4.01	3.12	0.89	2.23	3.12	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	15.61	11.71	1.95	3.90	0.00	0.98	2.44	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	28.12	17.42	1.53	4.28	1.22	1.53	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	55.31	39.04	3.25	6.51	6.51	19.52	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	33.09	20.85	2.32	3.31	0.33	1.32	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	35.03	12.04	1.09	2.74	1.09	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	28.95	6.88	2.53	2.53	2.17	2.17	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	25.98	12.81	3.20	1.07	1.42	1.78	1.07	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	29.83	10.74	1.19	1.19	2.39	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	26.14	9.62	2.30	1.76	0.95	0.68	1.08	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	16.16	5.39	1.35	0.54	0.81	0.54	1.35	0.54
immature langerhans cells, donor1	11904-125F5	38.50	52.06	6.30	7.02	4.12	0.97	2.91	2.42
immature langerhans cells, donor2	11905-125F6	70.50	20.60	7.13	3.17	4.75	3.96	0.00	0.00
insula, adult, pool1	10039-101F3	60.38	2.65	1.70	1.32	1.32	0.28	0.38	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	22.11	3.58	0.98	0.98	0.33	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	49.26	3.20	2.60	1.30	0.50	0.00	0.40	0.10
kidney, fetal, pool1	10045-101F9	67.76	6.37	2.05	1.41	1.13	0.64	0.57	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	29.54	12.92	0.57	2.70	0.85	0.28	1.42	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	22.53	1.24	0.69	0.00	0.14	0.55	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	41.65	1.83	0.37	0.18	0.18	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	33.24	3.27	2.18	1.09	0.00	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	21.74	1.01	1.01	0.00	1.52	1.01	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	22.44	3.01	1.37	1.09	0.55	0.00	0.82	0.00
leiomyoma cell line:10964C	10569-108B2	12.57	1.44	2.87	1.44	1.44	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	9.78	0.00	1.09	0.54	0.54	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	15.54	0.97	2.43	0.24	0.24	0.73	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	3.14	6.27	2.09	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	30.34	39.67	4.01	9.09	2.83	0.71	3.19	0.24
liposarcoma cell line:KMLS-1	10782-110G8	33.43	2.66	1.41	0.62	0.31	0.47	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	52.27	9.38	1.83	2.56	0.61	0.49	0.85	0.00
liver, adult, pool1	10018-101C9	38.57	1.30	1.78	0.32	0.65	0.16	0.00	0.16
liver, fetal, pool1	10086-102B5	20.70	6.58	0.94	0.94	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	60.66	1.02	3.35	0.15	0.29	0.58	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	62.19	0.55	2.03	0.18	0.18	0.55	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	38.37	0.00	2.26	0.85	0.28	1.97	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	63.09	1.68	3.36	0.00	0.84	0.84	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	27.68	1.66	1.66	0.42	0.00	0.14	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	17.92	5.52	0.00	2.07	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	28.21	3.95	1.45	0.79	0.53	0.53	0.53	0.00
lung, adult, pool1	10019-101D1	52.80	2.36	2.72	0.35	0.95	0.24	0.12	0.12
lung, fetal, donor1	10068-101I5	165.54	10.27	5.14	2.85	11.70	0.00	1.14	0.00
lung, right lower lobe, adult, donor1	10075-102A3	77.90	5.50	5.04	0.92	2.29	0.46	0.46	0.46
lymph node, adult, donor1	10077-102A5	52.54	11.36	8.99	3.79	1.42	0.95	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	34.63	7.67	1.75	0.66	1.53	0.22	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	18.26	28.83	5.13	5.43	2.57	0.91	1.96	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	48.42	2.55	2.55	0.00	0.00	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	31.97	2.66	0.89	0.44	0.44	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	35.69	4.36	0.83	0.62	0.83	0.83	0.42	0.00
mature adipocyte, donor3	12233-129G1	30.34	2.84	2.61	0.47	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	43.43	2.63	3.42	0.79	1.05	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	61.71	2.38	3.34	0.71	0.48	0.24	0.48	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	67.68	6.77	3.38	1.13	0.00	0.00	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	59.40	1.66	3.68	0.74	0.92	0.55	0.00	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	35.26	2.86	2.22	0.32	0.64	0.64	0.95	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	30.28	3.84	2.13	0.43	1.71	2.56	0.00	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	55.01	0.84	3.71	0.51	1.52	2.36	0.34	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	62.61	2.12	2.55	0.21	0.64	1.27	0.00	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	17.34	1.93	0.00	0.00	0.00	1.93	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	29.07	3.59	1.44	1.79	1.44	0.36	0.00	1.08
medulla oblongata - adult, donor10196	10174-103C3	63.60	3.89	1.30	0.00	0.00	1.30	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	61.77	1.86	3.10	0.31	0.62	0.62	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	61.71	1.47	1.63	0.41	0.73	0.16	0.00	0.00
medulla oblongata, newborn, donor10223	10361-105F1	36.45	0.35	3.12	0.00	0.00	0.35	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	54.69	8.86	1.77	1.99	0.44	1.11	0.66	0.00
medulloblastoma cell line:ONS-76	10759-110E3	20.66	3.91	1.10	0.61	0.24	0.12	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	37.81	12.07	2.16	4.02	1.44	0.72	1.15	0.00
melanoma cell line:G-361	10465-106H6	35.29	8.42	1.09	1.36	1.09	0.00	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	26.05	1.27	1.09	0.36	0.18	0.90	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	47.58	12.34	3.52	1.76	0.88	1.76	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	20.48	4.41	0.78	0.52	0.78	0.52	0.78	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	26.70	2.92	2.30	0.31	0.77	0.46	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	26.72	2.54	1.82	0.91	0.91	0.36	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	29.82	2.07	1.66	1.24	0.00	0.41	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.23	1.12	1.69	0.56	0.28	0.14	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	22.92	0.96	1.35	0.58	0.58	0.39	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.09	2.08	2.08	0.69	1.39	1.39	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.63	1.54	1.72	0.17	0.00	0.34	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	25.19	1.27	1.61	0.46	0.69	0.23	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.84	2.12	1.19	0.27	0.27	0.53	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	16.20	2.70	1.08	0.68	0.41	0.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.64	3.70	1.99	0.43	0.43	0.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	29.64	3.62	2.96	0.00	0.33	0.00	1.32	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	23.38	3.74	1.94	1.11	0.83	0.42	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	23.04	1.05	1.05	0.70	0.35	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.60	0.82	0.61	0.41	0.41	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.99	1.44	0.72	0.72	0.36	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.28	1.55	0.93	0.10	0.31	0.10	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.28	2.28	0.68	0.68	0.68	0.68	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	28.95	4.62	3.36	1.26	0.00	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.66	2.84	1.20	1.05	0.00	0.45	0.30	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.74	3.94	1.75	0.79	0.44	0.26	0.09	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	26.14	2.58	0.74	1.10	0.00	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	22.89	0.86	1.72	0.86	0.00	0.57	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.84	1.26	2.95	0.84	0.84	0.84	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.09	0.46	2.28	0.00	0.91	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.58	1.53	1.28	0.00	1.02	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	24.61	1.83	1.05	0.00	0.26	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.79	1.85	1.23	0.92	0.00	0.62	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	23.54	1.65	1.41	0.00	1.41	0.47	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	25.05	1.69	1.02	0.34	0.34	1.02	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	19.26	2.75	1.96	0.79	0.39	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	24.10	0.46	3.71	0.46	0.00	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.11	1.44	2.31	0.00	0.29	0.29	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	19.41	1.78	1.56	0.67	0.67	0.67	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	19.47	1.44	0.96	0.24	0.48	0.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.80	0.73	3.67	0.00	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	23.83	1.01	1.68	0.00	1.01	1.01	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.06	1.23	0.82	0.41	1.23	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	18.90	1.72	0.43	0.43	1.29	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	2.73	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	16.56	2.27	1.95	0.32	1.30	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	1.45	0.00	0.00	1.45	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.26	0.53	3.20	0.53	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.99	0.00	2.45	0.00	2.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	18.27	0.78	1.17	0.00	1.55	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	0.00	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	0.00	0.00	0.00	1.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.82	0.59	0.00	0.59	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	0.00	0.00	1.22	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.13	0.63	0.63	0.63	0.00	0.00	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	23.45	0.34	2.41	0.00	1.03	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	23.64	0.00	6.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	3.99	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	0.00	0.00	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	17.52	2.44	1.63	0.00	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	16.68	1.59	2.38	0.79	0.00	2.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	13.56	0.59	3.54	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.77	1.25	1.87	0.31	0.94	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	0.00	2.67	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	2.37	1.18	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	0.00	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.83	1.38	0.69	0.00	0.69	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	23.26	1.48	1.48	0.49	0.49	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	21.31	1.12	3.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	14.63	0.64	1.27	0.00	0.00	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.09	0.00	0.40	0.40	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	2.18	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	0.00	0.00	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	27.92	0.61	1.21	0.00	0.00	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	0.00	4.52	0.00	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.06	0.00	0.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	17.06	0.79	1.59	0.20	0.40	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.55	1.30	0.97	0.32	0.97	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	2.04	3.06	1.02	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	8.51	0.77	0.00	0.00	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	63.79	4.25	3.07	0.47	0.47	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	18.53	29.19	1.85	5.33	1.85	0.46	4.63	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	0.00	0.00	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.36	8.84	2.26	1.95	1.13	0.51	0.41	0.00
mesothelioma cell line:Mero-25	10850-111F4	21.56	15.21	2.72	0.45	0.91	0.68	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	30.07	3.42	1.96	0.00	0.24	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	13.06	3.32	1.99	0.89	0.22	0.00	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	29.96	20.50	1.58	1.58	1.31	2.10	2.37	0.53
mesothelioma cell line:Mero-83	10854-111F8	20.60	11.23	2.55	1.36	1.70	0.51	0.85	0.68
mesothelioma cell line:Mero-84	10855-111F9	5.81	7.84	1.01	1.01	0.51	0.76	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	21.12	6.42	2.07	2.07	0.41	0.62	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	23.36	4.31	1.66	0.50	0.17	0.00	0.50	0.33
mesothelioma cell line:NCI-H226	10846-111E9	16.11	13.94	1.81	2.90	1.45	0.72	0.72	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	30.41	9.05	2.39	2.39	1.02	0.34	0.51	0.00
mesothelioma cell line:NCI-H28	10845-111E8	22.14	15.27	2.29	2.04	0.76	0.51	2.80	0.00
mesothelioma cell line:No36	10857-111G2	18.27	3.91	0.98	1.30	0.00	0.33	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	15.99	4.06	1.35	0.54	1.08	0.27	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	32.43	8.83	2.49	0.58	1.54	0.38	0.19	0.38
migratory langerhans cells, donor2	11902-125F3	31.02	5.50	3.66	0.12	2.56	0.24	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	44.69	16.87	7.18	2.33	2.51	0.36	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	44.73	2.29	2.61	0.33	0.98	1.63	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	17.80	1.27	1.06	0.85	0.64	0.00	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	31.10	2.53	0.23	0.46	0.46	0.23	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	28.73	4.57	4.19	1.14	1.52	0.19	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	72.99	6.47	5.17	1.11	1.85	0.18	0.55	0.74
myeloma cell line:PCM6	10474-106I6	58.90	7.71	2.97	0.20	0.99	0.20	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	14.20	2.03	0.00	1.01	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.22	0.59	1.77	0.20	0.20	0.59	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	36.77	1.00	0.67	0.33	0.11	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	32.80	0.96	0.74	0.00	0.07	0.29	0.07	0.15
nasal epithelial cells, donor2	12227-129F4	35.88	2.76	0.00	0.00	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	37.73	14.03	1.15	3.91	1.84	0.00	1.15	0.23
neuroblastoma cell line:NB-1	10539-107G8	33.86	3.55	0.37	0.37	0.37	0.00	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	27.20	24.46	2.32	4.01	0.63	1.05	2.74	0.00
neuroblastoma cell line:NH-12	10555-107I6	53.86	6.15	2.42	1.49	1.68	0.00	0.75	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	42.23	4.03	2.37	2.61	0.95	1.19	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	37.06	11.25	1.27	2.38	1.58	0.32	0.48	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	18.11	14.29	1.21	1.01	1.01	0.20	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	13.99	17.17	0.00	0.00	2.54	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	30.61	2.40	1.86	0.53	0.53	0.00	0.00	0.27
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	95.05	72.05	4.23	12.51	4.57	1.35	1.69	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	15.21	0.00	0.80	1.60	0.00	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.85	2.89	0.64	0.32	0.64	0.32	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	29.17	2.36	2.36	0.00	0.79	0.79	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	60.37	2.81	1.97	1.12	1.50	0.19	0.19	0.19
occipital cortex - adult, donor10196	10172-103C1	82.42	2.06	2.06	0.00	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	72.46	1.34	2.95	0.81	0.00	0.81	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	34.94	1.82	3.28	0.73	1.82	0.00	0.00	1.46
occipital lobe, adult, donor1	10076-102A4	84.23	1.84	1.57	2.10	5.77	0.52	0.00	0.52
occipital lobe, fetal, donor1	10073-102A1	62.65	3.43	5.15	1.72	2.57	1.29	0.00	0.86
occipital pole, adult, pool1	10036-101E9	40.84	1.02	1.34	0.55	0.16	0.16	0.47	0.39
olfactory region, adult	10195-103E6	56.55	2.29	1.72	0.38	0.76	0.38	0.57	0.57
optic nerve, donor1	10277-104E7	96.05	2.00	12.01	2.00	0.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	35.99	4.67	1.25	0.68	0.23	0.34	0.57	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	35.45	10.44	0.82	1.24	0.14	0.00	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	34.03	2.37	2.37	1.86	0.51	1.19	0.34	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	40.31	4.27	1.73	1.16	0.12	0.58	0.23	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	18.23	1.18	0.00	0.00	0.29	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	16.82	11.21	0.00	0.00	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	37.11	10.18	1.48	1.06	1.06	0.21	0.00	0.42
ovary, adult, pool1	10020-101D2	60.88	3.58	2.80	0.70	1.31	0.70	0.35	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.82	2.57	0.37	0.37	0.00	0.00	0.37	0.00
pancreas, adult, donor1	10049-101G4	35.74	1.88	0.94	0.00	0.94	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	24.88	16.77	2.80	1.40	1.96	0.84	0.28	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	33.05	3.58	2.90	0.85	0.51	1.02	0.34	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	39.08	3.64	0.99	0.17	0.33	0.17	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	56.65	1.92	1.56	0.55	0.27	0.18	0.27	0.46
parietal cortex, adult, donor10258	10373-105G4	38.17	5.87	0.00	1.47	0.00	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	59.25	5.64	2.82	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	61.00	1.14	2.00	0.57	0.00	0.29	0.29	1.14
parietal lobe, adult, pool1	10034-101E7	49.61	2.73	1.23	0.70	0.70	0.09	0.18	0.35
parietal lobe, fetal, donor1	10072-101I9	110.56	4.85	6.79	0.97	1.94	1.94	0.97	2.91
parietal lobe, newborn, donor10223	10356-105E5	38.13	2.62	2.62	1.12	0.75	0.00	0.37	1.12
parotid gland, adult	10199-103F1	35.15	1.23	1.23	0.00	1.23	0.62	0.62	0.62
penis, adult	10200-103F2	55.86	1.07	3.22	1.07	0.54	0.54	0.00	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	59.87	4.83	3.90	0.93	1.49	0.37	0.19	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	35.55	2.33	1.17	0.58	0.29	0.29	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	72.24	1.29	2.58	0.65	0.65	0.65	0.65	1.29
pineal gland, adult, donor10252	10160-103A7	91.20	1.18	2.96	0.00	1.78	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	60.20	0.00	4.39	0.00	0.00	0.63	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	96.12	4.05	4.05	2.02	1.01	2.02	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	135.51	2.08	0.52	1.04	0.52	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	69.80	0.85	3.40	0.85	0.85	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	61.28	4.30	3.12	0.54	1.51	0.11	0.54	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	40.26	17.48	7.42	2.52	1.99	0.93	0.53	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	35.49	1.09	0.47	0.78	0.62	0.16	0.00	0.16
pons, adult, pool1	10033-101E6	53.88	1.89	0.95	0.26	0.60	0.00	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	52.74	1.57	1.74	0.87	0.78	0.26	0.26	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	29.28	37.65	2.09	8.37	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	5.51	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	33.21	7.57	0.58	1.60	1.02	0.15	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	26.86	8.17	0.54	2.36	0.73	0.18	0.73	0.00
prostate, adult, pool1	10022-101D4	56.41	2.09	1.63	0.36	0.91	0.09	0.54	0.09
putamen, adult, donor10196	10176-103C5	74.83	3.30	3.78	1.18	2.12	0.71	0.24	0.47
putamen, adult, donor10252	10152-102I8	33.33	5.88	1.96	0.00	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	6.56	1.09	0.00	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	41.80	3.87	1.69	0.72	0.24	0.00	0.72	0.24
putamen, newborn, donor10223	10365-105F5	69.72	0.00	5.25	2.25	0.75	0.00	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	36.66	4.36	1.16	1.75	0.29	0.00	0.58	0.29
rectum, fetal, donor1	10067-101I4	77.90	9.74	8.35	1.39	0.00	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	36.68	2.12	0.85	1.48	0.21	0.00	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	59.23	0.41	0.41	0.41	0.00	0.41	0.00	0.41
retina, adult, pool1	10030-101E3	83.00	3.28	3.08	0.60	0.89	0.10	0.40	0.10
retinoblastoma cell line:Y79	10475-106I7	34.29	8.57	1.04	1.04	0.78	0.00	0.78	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.29	14.02	0.61	2.34	0.25	0.25	1.97	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	21.93	9.00	0.84	3.09	0.84	0.00	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	27.28	2.27	0.76	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	33.99	3.72	1.29	0.65	0.16	0.65	0.32	0.00
salivary acinar cells, donor2	11772-123I8	49.84	3.58	2.48	0.28	0.83	0.69	0.14	0.00
salivary acinar cells, donor3	11773-123I9	24.50	1.99	0.00	0.66	0.00	0.66	0.66	0.66
salivary gland, adult, pool1	10093-102C3	56.05	1.14	0.57	1.14	0.00	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	51.68	4.22	2.02	0.42	1.18	0.08	0.42	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	51.49	3.17	1.88	0.71	1.06	0.12	0.24	0.12
seminal vesicle, adult	10201-103F3	80.95	1.06	2.12	2.12	2.12	1.59	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	38.14	4.37	2.92	1.70	0.24	2.43	1.94	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	22.65	2.77	1.26	0.25	0.50	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	26.09	4.01	2.01	1.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	29.01	5.78	1.34	1.75	0.13	0.13	1.21	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	32.16	2.10	0.44	0.11	0.55	0.11	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	38.32	4.26	2.71	0.65	0.77	0.13	0.65	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	32.63	0.00	0.71	2.13	2.13	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	31.06	1.20	0.48	0.60	0.84	0.12	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	24.12	2.01	1.01	1.01	0.00	3.02	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	84.58	3.79	4.42	1.89	0.63	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	25.68	2.67	1.33	0.67	0.00	0.00	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	26.79	3.47	2.21	0.32	0.95	0.63	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	36.62	3.85	1.93	1.54	0.39	0.96	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	38.57	5.60	0.49	1.32	0.49	0.33	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	40.05	0.64	0.00	0.48	0.00	0.16	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	26.80	2.83	1.09	0.65	0.44	0.00	0.44	0.00
small intestine, adult, pool1	10024-101D6	83.97	1.79	1.79	0.36	1.91	0.48	0.00	0.00
small intestine, fetal, donor1	10064-101I1	43.49	2.70	2.46	0.98	0.98	0.49	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	24.11	1.03	1.03	0.51	0.51	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	53.24	1.81	1.81	0.26	0.52	1.29	0.52	0.78
somatostatinoma cell line:QGP-1	10781-110G7	21.17	1.07	0.27	0.00	0.00	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	84.19	3.44	3.67	0.92	1.38	1.15	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	76.09	1.18	3.15	0.39	0.79	0.39	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	62.95	2.08	2.08	0.69	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	101.23	1.22	3.05	1.83	3.05	0.61	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	46.38	2.30	3.21	0.00	0.46	1.38	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	18.22	1.64	0.30	0.30	0.30	0.00	0.00	0.00
spleen, adult, pool1	10025-101D7	51.32	15.31	4.74	1.65	3.85	0.33	1.10	0.55
spleen, fetal, pool1	10044-101F8	57.92	15.57	4.53	2.15	2.07	0.64	1.43	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	29.50	12.73	3.31	2.90	2.28	0.31	1.45	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	45.19	1.71	1.52	0.38	0.95	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	42.98	2.80	2.10	1.40	0.70	1.40	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	42.61	2.35	1.17	0.00	0.78	1.17	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	54.48	0.45	0.34	0.23	0.56	0.11	0.11	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	43.21	5.51	1.69	1.69	0.85	0.42	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	13.54	8.04	1.27	1.69	1.27	0.00	0.85	0.42
stomach, fetal, donor1	10062-101H8	58.74	8.54	0.00	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	44.44	1.71	3.99	0.57	1.14	0.00	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	54.27	0.00	54.27	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	67.09	1.66	3.12	0.42	1.25	0.21	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	32.07	2.07	1.03	0.00	0.52	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	45.93	2.12	3.53	0.00	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	17.19	23.16	1.38	6.42	1.60	0.23	1.83	0.23
temporal lobe, adult, pool1	10031-101E4	42.39	1.10	2.03	0.85	0.68	0.17	0.17	0.59
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	64.10	7.83	3.56	0.00	1.42	0.71	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	50.55	3.52	6.59	0.44	1.32	0.88	0.44	0.44
tenocyte, donor1	11763-123H8	36.31	1.75	0.70	0.00	0.00	0.35	0.00	0.35
tenocyte, donor2	11765-123I1	29.76	3.05	1.91	0.38	0.00	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	26.69	1.11	1.48	0.00	0.37	1.11	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	13.43	24.47	1.36	2.04	1.19	0.68	1.36	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	21.58	12.79	1.23	1.08	0.31	0.62	0.31	0.15
teratocarcinoma cell line:PA-1	10807-111A6	24.33	22.32	1.70	3.87	1.24	0.15	1.86	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	16.25	13.58	1.40	1.78	1.27	0.38	0.63	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	31.01	21.56	3.40	3.40	1.51	0.38	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	36.86	22.14	4.04	1.64	1.74	1.09	0.87	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	16.29	8.14	1.63	2.61	0.98	1.30	0.65	0.00
testis, adult, pool1	10026-101D8	59.27	6.12	3.76	1.29	2.90	0.86	0.86	0.43
testis, adult, pool2	10096-102C6	96.53	13.98	9.02	2.71	1.80	2.71	0.45	0.90
thalamus - adult, donor10196	10168-103B6	80.59	0.00	3.31	0.00	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	79.55	1.09	2.50	0.78	0.16	0.94	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	0.00	0.00	0.00	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	34.09	0.49	1.48	0.33	0.16	0.49	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	45.45	0.58	1.73	0.00	0.58	0.58	0.00	2.30
throat, adult	10209-103G2	67.16	2.50	1.75	1.25	1.25	0.50	0.25	0.25
throat, fetal, donor1	10061-101H7	66.12	3.96	2.13	0.61	1.83	2.74	1.22	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	18.48	13.51	0.99	2.78	0.20	0.79	1.19	0.00
thymus, adult, pool1	10027-101D9	60.34	29.13	6.36	7.06	3.18	0.40	1.49	0.10
thymus, fetal, pool1	10043-101F7	76.06	46.96	5.61	8.21	4.57	0.31	3.01	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	41.08	2.79	2.13	1.06	1.20	0.27	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	65.38	2.24	1.54	0.42	0.56	0.42	0.14	0.28
thyroid, adult, pool1	10028-101E1	62.99	1.59	1.77	0.37	0.93	0.28	0.19	0.09
thyroid, fetal, donor1	10060-101H6	71.19	3.95	2.11	0.00	1.05	1.85	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	0.00	6.16	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	47.21	2.33	2.33	0.70	2.09	0.93	0.00	0.93
tongue, fetal, donor1	10059-101H5	35.07	1.18	1.58	0.39	0.79	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	77.04	10.32	4.01	2.60	3.01	0.10	0.90	0.00
trachea, adult, pool1	10029-101E2	46.22	2.21	1.64	0.65	0.74	0.08	0.33	0.00
trachea, fetal, donor1	10058-101H4	72.32	3.46	3.85	0.38	0.38	1.15	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.14	3.19	1.42	0.35	0.35	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	30.50	11.04	1.42	2.23	0.91	0.30	1.11	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	43.56	2.04	0.78	0.47	0.47	0.16	0.63	0.00
tridermal teratoma cell line:HGRT	10694-109G1	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	29.29	2.96	0.08	0.25	0.42	0.17	0.59	0.08
umbilical cord, fetal, donor1	10057-101H3	45.90	2.09	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	113.81	10.24	2.73	1.19	2.56	0.68	0.34	0.00
uterus, fetal, donor1	10055-101H1	48.12	5.63	4.10	1.02	2.05	1.54	0.00	0.00
vagina, adult	10204-103F6	40.71	3.23	0.65	0.00	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	50.20	8.11	6.80	1.32	3.07	0.66	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	22.16	18.43	5.87	1.87	1.60	0.80	1.07	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000508620.5:-130 ENST00000514095.5:-130 ENST00000296783.7:-132 AK095818:-132 ENST00000502269.1:-185 ENST00000515807.5:-202 ENST00000428308.6:-220 BC026061:-220 ENST00000453514.6:-264 NM_001388124.1:-264 NM_001388108.1:-264 NM_001388094.1:-264 NM_001388120.1:-264 NM_001388121.1:-264 NM_001297744.3:-264 NM_001388133.1:-264 NM_001114393.3:-264 NM_001349548.2:-264 NM_001388119.1:-264 NM_001388110.1:-264 NM_001349550.2:-264 NM_001388111.1:-264 NM_001388112.1:-264 NM_001388096.1:-264 NM_001388134.1:-264 NM_001388128.1:-264 NM_001388097.1:-264 NM_173797.5:-264 NM_001388093.1:-264 NM_001388116.1:-264 NM_001388107.1:-264 NM_001388125.1:-264 NM_001388102.1:-264 NM_001388117.1:-264 NM_001388122.1:-264 NM_001388106.1:-264 NM_001388129.1:-264 NM_001388109.1:-264 NM_001388136.1:-264 NM_001388137.1:-264 NM_001388118.1:-264 NM_001388105.1:-264 NM_001388132.1:-264 NM_001388131.1:-264 NM_001388130.1:-264 NM_001388098.1:-264 NM_001388113.1:-264 NM_001388135.1:-264 NM_001388114.1:-264 NM_001349551.2:-264 NM_001297745.3:-264 NM_001114394.3:-264 NM_001349549.2:-264 NM_001388101.1:-264 NM_001388099.1:-264 NM_001388127.1:-264 NM_001349554.2:-264 NM_001349552.2:-264 NM_001388100.1:-264 NM_001388123.1:-264 NM_001349553.2:-264 NM_001388095.1:-264 NM_001388115.1:-264 NM_001388103.1:-264 NM_001388126.1:-264 BC047581:-264 ENST00000504233.5:-270 AL833136:-270 ENST00000423041.6:-272" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.